661 results on '"Bateman, G."'
Search Results
352. Time-dependent simulations of a Compact Ignition Tokamak
- Author
-
Bateman, G
- Published
- 1988
- Full Text
- View/download PDF
353. High pressure tokamaks. [Review of equilibrium and stability problems]
- Author
-
Bateman, G.
- Published
- 1978
- Full Text
- View/download PDF
354. Inductive effects in flux conserving tokamaks
- Author
-
Bateman, G.
- Published
- 1978
- Full Text
- View/download PDF
355. Overview of JET results
- Author
-
F. Romanelli, F. Laxaback, I. Abel, V. Afanesyev, G. Agarici, K. M. Aggarwal, M. Airila, R. Akers, T.h. Alarcon, A. Alexeev, A. Alfier, P. Allan, S. Almaviva, A. Alonso, M. Alonso, B. Alper, H. Altmann, D. Alves, V. Amosov, G. Anda, F. Andersson, E. Andersson Sund́en, V. Andreev, Y. Andrew, M. Angelone, M. Anghel, A. Anghel, C. Angioni, G. Apruzzese, N. Arcis, P. Arena, A. Argouarch, M. Ariola, A. Armitano, R. Armstrong, G. Arnoux, S. Arshad, G. Artaserse, J. F. Artaud, A. Ash, E. Asp, O. Asunta, C. V. Atanasiu, G. Atkins, M. D. Axton, C. Ayres, A. Baciero, V. Bailescu, B. Baiocchi, R. A. Baker, I. Balboa, C. Balorin, N. Balshaw, J. W. Banks, Y. F. Baranov, D. Barbier, I. L. Barlow, M. A. Barnard, R. Barnsley, L. Barrena, L. Barrera, M. Baruzzo, V. Basiuk, G. Bateman, P. Batistoni, N. Baumgarten, L. Baylor, B. Bazylev, P. S. Beaumont, K. Beausang, M. B́ecoulet, N. Bekris, M. Beldishevski, A. C. Bell, F. Belli, M. Bellinger, P. S. A. Belo, ́.E. Belonohy, P. E. Bennett, N. A. Benterman, G. Berger By, H. Bergsåker, H. Berk, J. Bernardo, B. Bertrand, M. N. A. Beurskens, B. Bieg, B. Bienkowska, T. Biewer, T. M. Biewer, M. Bigi, R. Bilato, J. Bird, J. Bizarro, T. R. Blackman, P. Blanchard, E. Blanco, J. Blum, V. Bobkov, A. Boboc, D. Boilson, I. Bolshakova, T. Bolzonella, L. Boncagni, G. Bonheure, X. Bonnin, D. Borba, A. Borthwick, A. Botrugno, C. Boulbe, F. Bouquey, C. Bourdelle, K. v. Bovert, M. Bowden, T. Boyce, H. J. Boyer, A. Bozhenkov, R. J. Brade, J. M. A. Bradshaw, J. Braet, V. Braic, G. C. Braithwaite, C. Brault, H. Braune, B. Breizman, S. Bremond, P. D. Brennan, A. Brett, J. Breue, S. Brezinsek, M. D. J. Bright, F. Briscoe, M. Brix, M. Brombin, B. C. Brown, D. P. D. Brown, A. Bruschi, J. Brzozowski, J. Bucalossi, M. A. Buckley, T. Budd, R. Budny, R. V. Budny, P. Bunting, P. Buratti, G. Burcea, P. R. Butcher, R. J. Buttery, R. Caç̃ao, G. Calabr`o, C. P. Callaghan, J. P. Caminade, P. G. Camp, D. C. Campling, J. Canik, B. Cannas, A. J. Capel, P. J. Card, A. Cardinali, T. Carlstrom, P. Carman, D. Carralero, L. Carraro, T. Carter, B. B. Carvalho, P. Carvalho, A. Casati, C. Castaldo, J. Caughman, R. Cavazzana, M. Cavinato, M. Cecconello, F. E. Cecil, A. Cenedese, C. Centioli, R. Cesario, C. D. Challis, M. Chandler, C. Chang, A. Chankin, I. T. Chapman, D. J. Child, P. Chiru, G. Chitarin, I. Chugonov, I. Chugunov, D. Ciric, F. Clairet, R. H. Clarke, R. Clay, M. Clever, J. P. Coad, P. A. Coates, V. Cocilovo, S. Coda, R. Coelho, J. Coenen, I. Coffey, L. Colas, M. Cole, S. Collins, S. Combs, J. Compan, J. E. Conboy, S. Conroy, N. Cook, S. P. Cook, D. Coombs, S. R. Cooper, Y. Corre, G. Corrigan, S. Cortes, D. Coster, G. F. Counsell, X. Courtois, M. Cox, T. Craciunescu, S. Cramp, F. Crisanti, O. Croft, K. Crombe, B. J. Crowley, N. Cruz, L. Cupido, M. Curuia, R. A. Cusack, A. Czarnecka, S. Dalley, E. T. Daly, A. Dalziel, D. Darrow, O. David, N. Davies, J. J. Davis, I. E. Day, C. Day, R. De Angelis, G. deArcas, M. R. de Baar, E. delaCal, E. de la Luna, J. L. de Pablos, G. De Temmerman, P. C. de Vries, F. Degli Agostini, E. Delabie, D. del Castillo Negrete, L. Delpech, G. Denisov, A. J. Denyer, R. F. Denyer, S. Devaux, P. Devynck, L. Di Matteo, L. DiPace, P. J. Dirken, A. Dnestrovskiy, D. Dodt, K. Dominiczak, S. E. Dorling, D. Douai, A. P. Down, P. T. Doyle, J. R. Drake, T. Dreischuh, V. Drozdov, P. Dumortier, D. Dunai, I. Duran, F. Durodíe, K. Dylst, R. Eaton, T. Edlington, A. M. Edwards, D. T. Edwards, P. K. Edwards, T.h. Eich, A. Ekedahl, T. Elevant, A. Elfimov, B. Ellingboe, C. G. Elsmore, B. Emmoth, G. Ericsson, L. G. Eriksson, A. Eriksson, B. Esposito, H. G. Esser, T. Estrada, E. A. Evangelidis, G. E. Evans, G. D. Ewart, D. T. Ewers, G. Falchetto, D. Falie, J. G. A. Fanthome, D. Farina, J. W. Farthing, A. Fasoli, B. Faugeras, N. Fedorczak, R. C. Felton, C. Fenzi, H. Fernandes, J. A. Ferreira, J. Ferreira, J. Ferron, J. A. Fessey, L. Figini, A. Figueiredo, J. Figueiredo, P. Finburg, K. H. Finken, U. Fischer, N. Fitzgerald, J. Flanagan, C. Fleming, A. Fonseca, A. D. Forbes, O. Ford, A. Formisano, D. Fraboulet, R. J. Francis, L. Frassinetti, R. Fresa, J. P. Friconneau, D. Frigione, J. C. Fuchs, K. Fullard, W. Fundamenski, M. Furno Palumbo, J. Gafert, K. Ǵal, R. Galṽao, S. Garavaglia, X. Garbet, J. Garcia, M. Gar cia Munoz, W. Gardner, P. Garibaldi, D. Garnier, L. Garzotti, M. Gatu Johnson, P. Gaudio, E. Gauthier, J. W. Gaze, D. F. Gear, J. Gedney, S. J. Gee, M. Gelfusa, E. Genangeli, S. Gerasimov, A. Geraud, T. Gerbaud, M. Gherendi, N. Ghirelli, J. C. Giacalone, L. Giacomelli, C. S. Gibson, C. Gil, S. J. Gilligan, C. G. Gimblett, D. Gin, E. Giovannozzi, C. Giroud, G. Giruzzi, S. Glowacz, J. Godwin, J. K. Goff, P. Gohil, V. Goloborod’ko, B. Gonçalves, M. Goniche, S. Gonzales, S. M. Gonźalezde Vicente, A. Goodyear, N. Gorelenkov, G. Gorini, R. Goulding, B. Graham, D. Graham, M. E. Graham, G. Granucci, J. Graves, N. R. Green, H. Greuner, E. Grigore, F. S. Griph, C. Grisolia, G. Gros, G. Grossetti, M. Groth, S. Gr̈unhagen, M. P. Gryaznevich, R. Guirlet, B. Gulejova, J. Gunn, A. Gupta, P. Guzdar, P. Hacek, L. J. Hackett, S. Hacquin, B. Haist, A. Hakola, S. J. Hall, S. P. HallworthCook, D. T. Hamilton, H. Han, R. C. Handley, S. Harding, J. D. W. Harling, D. Harting, M. J. Harvey, T. D. V. Haupt, E. Havlickova, N. C. Hawkes, R. Hawryluk, J. H. Hay, N. Hayashi, P. W. Haydon, I. R. Hayward, S. Hazel, P. J. L. Heesterman, W. Heidbrink, J. Heikkinen, C. Hellesen, T. Hellsten, O. N. Hemming, T. C. Hender, M. Henderson, C. Hennig, V. Hennion, C. Hidalgo, S. Higashijima, J. W. Hill, M. Hill, K. Hill, J. Hillairet, D. Hillis, T. Hirai, M. Hitchin, J. Hobirk, C. Hogan, C. H. A. Hogben, G. M. D. Hogeweij, I. C. Hollingham, R. Holyaka, D. A. Homfray, G. Honeyands, S. H. Hong, C. Hopf, B. A. Horn, A. R. Horton, L. D. Horton, S. P. Hotchin, M. R. Hough, W. Houlberg, D. F. Howell, M. Hron, A. Huber, T. M. Huddleston, Z. Hudson, M. Hughes, M. Ḧuhnerbein, C. C. Hume, A. J. Hunt, C. L. Hunter, T. S. Hutchinson, S. Huygen, G. Huysmans, V. Hyn̈onen, S. Ide, R. Igreja, C. Illescas, F. Imbeaux, D. Ivanova, E. Ivings, S. Jachmich, G. Jackson, P. Jacquet, K. Jakubowska, M. Jakubowski, P. V. James, R. J. E. Jaspers, S. Jednorog, I. Jenkins, M. A. C. Jennison, C. Jeskins, O. Jin Kwon, E. Joffrin, M. F. Johnson, R. Johnson, T. Johnson, D. Jolovic, V. Jonauskas, E. M. Jones, G. Jones, H. D. Jones, T. T. C. Jones, M. Jouvet, C. Juṕen, I. Kachtchouk, J. Kaczmarczyk, A. Kallenbach, J. K̈allne, D. Kalupin, S. Ḱalvin, G. Kamelander, R. Kamendje, A. Kappatou, S. Karttunen, W. Kasparek, I. Katramados, M. Kaufmann, G. Kaveney, A. S. Kaye, M. J. Kear, D. L. Keeling, D. Kelliher, M. Kempenaars, P. Khilar, N. G. Kidd, M. Kiisk, K. M. Kim, R. F. King, D. J. Kinna, V. Kiptily, G. Kirnev, N. Kirneva, K. Kirov, A. Kirschner, R. Kisielius, D. Kislov, G. Kiss, T. Kiviniemi, G. Kizane, A. Klein, A. Klix, M. Knaup, K. Kneuper, H. Kneupner, P. J. Knight, S. J. Knipe, M. Kocan, F. K̈ochl, G. Kocsis, C. Konz, T. Koppitz, A. Korotkov, H. R. Koslowski, V. Kotov, M. D. Kovari, K. Kovarik, G. Kramer, A. Krasilnikov, V. Krasilnikov, S. Kraus, A. Kreter, K. Krieger, A. Kritz, Y. Krivchenkov, U. Kruezi, M. Krychowiak, S. Krylov, I. Ksiazek, M. Kubic, S. Kuhn, W. K̈uhnlein, T. Kurki Suonio, A. Kurowski, B. Kuteev, A. Kuyanov, R. La Haye, M. Laan, C. Labate, A. Lachichi, N. Lam, P. Lang, M. T. Large, I. Lassiwe, J. R. Last, K. D. Lawson, M. Laxåback, R. A. Layne, E. Lazzaro, F. LeGuern, B. LeBlanc, H. J. Leggate, M. Lehnen, M. Leigheb, I. Lengar, M. Lennholm, E. Lerche, C. N. Lescure, Y. Li, A. Li Puma, Y. Liang, J. Likonen, Y. Lin, J. Linke, S. A. Linstead, B. Lipshultz, X. Litaudon, A. G. Litvak, Y. Liu, T. Loarer, A. Loarte, R. C. Lobel, P. J. Lomas, F. D. Long, J. L̈onnroth, D. J. Looker, J. Lopez, P.h. Lotte, M. J. Loughlin, A. B. Loving, C. Lowry, T. Luce, R. M. A. Lucock, A. Lukanitsa, A. M. Lungu, C. P. Lungu, A. Lyssoivan, P. Macheta, A. S. Mackenzie, M. Macrae, G. Maddaluno, G. P. Maddison, J. Madsen, P. Maget, C. Maggi, H. Maier, J. Mailloux, M. Makowski, C. J. Manning, M. Mansfield, M. E. Manso, P. Mantica, M. Mantsinen, M. Maraschek, C. Marchetto, M. A. Marchitti, M. Mardenfeld, J. L. Marechal, M. Marinelli, A. Marinoni, M. Marinucci, J. M̈arki, D. Marocco, C. A. Marren, D. Martin, D. L. Martin, G. Martin, Y. Martin, J. R. Mart́ın Soĺıs, K. Masaki, A. Masiello, M. Maslov, C. Maszl, A. Matilal, M. Mattei, G. F. Matthews, F. Maviglia, C. R. May, M. Mayer, M. L. Mayoral, D. Mazon, C. Mazzotta, E. Mazzucato, P. McCarthy, K. G. McClements, K. McCormick, P. A. McCullen, D. McCune, D. C. McDonald, R. Mcgregor, J. P. Mckivitt, A. Meakins, F. Medina, A. G. Meigs, M. Menard, L. Meneses, S. Menmuir, I. R. Merrigan, P.h. Mertens, A. Messiaen, H. Meyer, M. Miele, P. Migliucci, A. G. Miller, S. F. Mills, J. J. Milnes, K. Min Kim, T. Mindham, F. Mirizzi, E. Mirones, M. Mironov, R. Mitteau, J. Mlynar, P. Mollard, I. Monakhov, P. Monier Garbet, R. Mooney, S. Moradi, D. Moreau, P.h. Moreau, L. Moreira, A. Morgan, P. D. Morgan, C. Morlock, A. Moro, A. W. Morris, G. L. Mort, C. Mrozek, A. Mueck, H. W. M̈uller, M. Murakami, A. Murari, I. Mustata, F. Nabais, E. Nardon, G. Nash, V. Naulin, M. F. F. Nave, R. Nazikian, I. Nedzelski, C. R. Negus, J. D. Neilson, A. Neto, R. Neu, O. Neubauer, G. J. Newbert, M. Newman, K. J. Nicholls, A. Nicolai, L. Nicolas, P. Nieckchen, P. Nielsen, A. H. Nielsen, S. K. Nielsen, G. Nielson, J. Nieto, M. P. S. Nightingale, C. Noble, M. Nocente, M. Nora, H. Nordman, M. Norman, J. M. Noterdaeme, S. Nowak, I. Nunes, F. Ognissanto, T. O’Gorman, S. Olariu, A. Oleynikov, M. O’Mullane, J. Ongena, F. Orsitto, O. I. Oswuigwe, M. Ottaviani, N. Oyama, D. Pacella, K. Paget, S. Palazzo, J. Pamela, S. Pamela, R. Panek, L. Pangione, A. Panin, T.h. Panis, A. Pankin, A. Pantea, V. Parail, T.h. Parisot, A. Parkin, A. Parsloe, B. T. Parsons, R. Pasqualotto, P. Pastor, R. Paterson, M. K. Paul, D. Peach, R. J. H. Pearce, B. J. Pearson, I. J. Pearson, L. C. Pedrick, M. A. Pedrosa, B. Pegourie, R. Pereira, E. Perelli Cippo, G. Pereverzev, A. Perevezentsev, C.h. PerezvonThun, V. Pericoli Ridolfini, A. Perona, Y. Perrot, S. Peruzzo, S. Peschanyy, G. Petravich, L. Petrizzi, V. Petrov, V. Petrzilka, V. Philipps, G. Piazza, F. Piccolo, A. Pietropaolo, M. Pillon, S. D. Pinches, T. Pinna, G. Pintsuk, P. Piovesan, F. Pisano, R. Pitts, B. Plaum, V. Plyusnin, M. Polasik, F. M. Poli, N. Pomaro, O. Pompilian, L. Poncet, P. J. Pool, S. Popovichev, F. Porcelli, M. T. Porfiri, C. Portafaix, A. Pospieszczyk, G. Possnert, G. Prestopino, P. Prior, R. Prokopowicz, I. Proverbio, R. Pugno, M. E. Puiatti, K. Purahoo, V. Pustovitov, T.h. P̈utterich, D. P̈uttmann Kneupner, E. Rachlew, R. Rademaker, T. Rafiq, M. S. J. Rainford, G. Ramogida, K. Rantam̈aki, J. Rapp, J. J. Rasmussen, G. Ratt́a, G. Ravera, M. Reich, R. Reichle, D. Reiser, R. Reiss, D. Reiter, D. Rendell, C. Reux, G. Rewoldt, T. T. Ribeiro, V. Riccardo, D. Richards, F. Rigollet, F. G. Rimini, L. Rios, M. Riva, J. E. C. Roberts, R. J. Robins, D. S. Robinson, S. A. Robinson, D. W. Robson, H. Roche, M. R̈odig, N. Rodionov, V. Rohde, A. Rolfe, M. Romanelli, A. Romano, J. Romero, E. Ronchi, S. Rosanvallon, C.h. Roux, S. Rowe, M. Rubel, L. Ruchko, M. Ruiz, C. Ruset, M. Russell, A. Ruth, L. Ryc, A. Rydzy, F. Ryter, J. Rzadkiewicz, S. Saarelma, F. Sabathier, R. Sabot, S. Sadakov, P. Sagar, G. Saibene, A. Saille, F. Saint Laurent, A. Salmi, R. Salomaa, F. Salzedas, U. Samm, P. Sanchez, S. Sanders, S. G. Sanders, G. Sandford, K. Sandland, P. Sandquist, D. E. G. Sands, M. I. K. Santala, F. Sartori, R. Sartori, O. Sauter, A. Savelyev, A. Savtchkov, S. C. Scales, A. Scarabosio, N. Schaefer, C.h. Schlatter, V. Schmidt, A. Schmidt, O. Schmitz, S. Schmuck, M. Schneider, M. Scholz, K. Scḧopf, B. Schweer, J. Schweinzer, B. Scott, M. Seki, L. Semeraro, A. Semerok, G. Sergienko, F. Serra, M. Sertoli, M. M. J. Shannon, S. E. Sharapov, S. R. Shaw, A. Shevelev, R. Sievering, C. A. Silva, P. A. Simmons, A. Simonetto, D. Simpson, S. Sipila, A. C. C. Sips, A. Sirinelli, H. Sj̈ostrand, D. Skopintsev, K. S.l.a.b.k.o.w.s.k.a., P. G. Smith, J. Snipes, L. Snoj, S. Snyder, S. Soare, E. R. Solano, S. Soldatov, A. Soleto, W. Solomon, C. Soltane, P. Sonato, A. Sopplesa, A. Sorrentino, J. Sousa, C. B. C. Sowden, C. Sozzi, P. Sp̈ah, T. Spelzini, J. Spence, F. Spineanu, P. Spuig, A. Sẗabler, R. D. Stagg, M. F. Stamp, V. Stancalie, P. Stangeby, C. Stan Sion, D. E. Starkey, M. J. Stead, A. V. Stephen, A. L. Stevens, J. Stober, R. B. Stokes, D. Stork, D. Stoyanov, J. Strachan, P. Strand, M. Stransky, D. Strauss, D. Strintzi, W. Studholme, Y. SuNa, F. Subba, H. P. Summers, Y. Sun, C. Surdu Bob, E. Surrey, D. J. Sutton, J. Svensson, D. Swain, B. D. Syme, I. D. Symonds, T. Szepesi, A. Szydlowski, F. Tabares, V. Takalo, H. Takenaga, T. Tala, A. R. Talbot, C. Taliercio, C. Tame, G. Tardini, M. Tardocchi, L. Taroni, G. Telesca, A. Terra, A. O. Terrington, D. Testa, J. M. Theis, J. D. Thomas, P. D. Thomas, P. R. Thomas, V. K. Thompson, H. Thomsen, C. Thomser, A. Thyagaraja, P. A. Tigwell, I. Tiseanu, R. Tivey, J. M. Todd, T. N. Todd, M. Z. Tokar, S. Tosti, P. Trabuc, J. M. Travere, W. Treutterer, P. Trimble, A. Trkov, E. Trukhina, M. Tsalas, H. Tsige Tamirat, E. Tsitrone, D. Tskhakaya jun, O. Tudisco, S. Tugarinov, M. M. Turner, G. Turri, S. G. J. Tyrrell, N. Umeda, B. Unterberg, H. Urano, A. J. Urquhart, I. Uytdenhouwen, A. Vaccaro, A. P. Vadgama, G. Vagliasindi, D. Valcarcel, M. Valisa, J. Vallory, M. Valovic, D. Van Eester, B. van Milligen, G. J. van Rooij, C. A. F. Varandas, S. Vartanian, V. Vdovin, J. Vega, G. Verdoolaege, J. M. Verger, L. Vermare, C. Verona, T.h. Versloot, M. Vervier, J. Vicente, S. Villari, E. Villedieu, F. Villone, J. E. Vince, G. J. Vine, B. Viola, E. Vitale, R. Vitelli, M. Vlad, I. Voitsekhovitch, M. Vrancken, K. Vulliez, C. W. F. Waldon, M. Walker, M. J. Walsh, J. Waterhouse, M. L. Watkins, M. J. Watson, T. Wauters, M. W. Way, C. R. Webb, J. Weiland, H. Weisen, M. Weiszflog, R. Wenninger, A. T. West, J. M. Weulersse, B. Weyssow, M. R. Wheatley, A. D. Whiteford, A. M. Whitehead, A. G. Whitehurst, A. M. Widdowson, R. C. Wieggers, C. Wiegmann, S. Wiesen, A. Wilson, D. Wilson, D. J. Wilson, H. R. Wilson, M. Wischmeier, D. M. Witts, R. C. Wolf, J. Wolowski, P. Woscov, G. M. Wright, J. Wright, G. S. Xu, V. Yavorskij, V. Yerashok, J. Yorkshades, C. Young, D. Young, I. D. Young, X. Yuhong, L. Zabeo, A. Zabolotsky, L. Zaccarian, R. Zagorski, F. S. Zaitsev, S. Zajac, L. Zakharov, R. Zanino, V. Zaroschi, K. D. Zastrow, I. Zatz, B. Zefran, W. Zeidner, M. Zerbini, T. Zhang, Y. Zhu, E. Zilli, O. Zimmermann, V. Zoita, S. Zoletnik, W. Zwingman, JET EFDA Contributors, ALBANESE, Raffaele, AMBROSINO, GIUSEPPE, BELLIZIO, TERESA, CARANNANTE, GIUSEPPE, COCCORESE, VINCENZO, DE TOMMASI, GIANMARIA, MIANO, GIOVANNI, PIRONTI, ALFREDO, QUERCIA, ANTONIO, RUBINACCI, GUGLIELMO, J., Pamela, EMILIA R., Solano, AND JET EFDA, Contributor, J. M., Adam, G., Agarici, M., Agarici, H., Akhter, Albanese, Raffaele, Romanelli, F., Laxaback, F., Abel, I., Afanesyev, V., Agarici, G., Aggarwal, K. M., Airila, M., Akers, R., Alarcon, T. h., Alexeev, A., Alfier, A., Allan, P., Almaviva, S., Alonso, A., Alonso, M., Alper, B., Altmann, H., Alves, D., Ambrosino, Giuseppe, Amosov, V., Anda, G., Andersson, F., Andersson Sund́en, E., Andreev, V., Andrew, Y., Angelone, M., Anghel, M., Anghel, A., Angioni, C., Apruzzese, G., Arcis, N., Arena, P., Argouarch, A., Ariola, M., Armitano, A., Armstrong, R., Arnoux, G., Arshad, S., Artaserse, G., Artaud, J. F., Ash, A., Asp, E., Asunta, O., Atanasiu, C. V., Atkins, G., Axton, M. D., Ayres, C., Baciero, A., Bailescu, V., Baiocchi, B., Baker, R. A., Balboa, I., Balorin, C., Balshaw, N., Banks, J. W., Baranov, Y. F., Barbier, D., Barlow, I. L., Barnard, M. A., Barnsley, R., Barrena, L., Barrera, L., Baruzzo, M., Basiuk, V., Bateman, G., Batistoni, P., Baumgarten, N., Baylor, L., Bazylev, B., Beaumont, P. S., Beausang, K., B́ecoulet, M., Bekris, N., Beldishevski, M., Bell, A. C., Belli, F., Bellinger, M., Bellizio, Teresa, Belo, P. S. A., Belonohy, ́. E., Bennett, P. E., Benterman, N. A., Berger By, G., Bergsåker, H., Berk, H., Bernardo, J., Bertrand, B., Beurskens, M. N. A., Bieg, B., Bienkowska, B., Biewer, T., Biewer, T. M., Bigi, M., Bilato, R., Bird, J., Bizarro, J., Blackman, T. R., Blanchard, P., Blanco, E., Blum, J., Bobkov, V., Boboc, A., Boilson, D., Bolshakova, I., Bolzonella, T., Boncagni, L., Bonheure, G., Bonnin, X., Borba, D., Borthwick, A., Botrugno, A., Boulbe, C., Bouquey, F., Bourdelle, C., Bovert, K. v., Bowden, M., Boyce, T., Boyer, H. J., Bozhenkov, A., Brade, R. J., Bradshaw, J. M. A., Braet, J., Braic, V., Braithwaite, G. C., Brault, C., Braune, H., Breizman, B., Bremond, S., Brennan, P. D., Brett, A., Breue, J., Brezinsek, S., Bright, M. D. J., Briscoe, F., Brix, M., Brombin, M., Brown, B. C., Brown, D. P. D., Bruschi, A., Brzozowski, J., Bucalossi, J., Buckley, M. A., Budd, T., Budny, R., Budny, R. V., Bunting, P., Buratti, P., Burcea, G., Butcher, P. R., Buttery, R. J., Caç̃ao, R., Calabr`o, G., Callaghan, C. P., Caminade, J. P., Camp, P. G., Campling, D. C., Canik, J., Cannas, B., Capel, A. J., Carannante, Giuseppe, Card, P. J., Cardinali, A., Carlstrom, T., Carman, P., Carralero, D., Carraro, L., Carter, T., Carvalho, B. B., Carvalho, P., Casati, A., Castaldo, C., Caughman, J., Cavazzana, R., Cavinato, M., Cecconello, M., Cecil, F. E., Cenedese, A., Centioli, C., Cesario, R., Challis, C. D., Chandler, M., Chang, C., Chankin, A., Chapman, I. T., Child, D. J., Chiru, P., Chitarin, G., Chugonov, I., Chugunov, I., Ciric, D., Clairet, F., Clarke, R. H., Clay, R., Clever, M., Coad, J. P., Coates, P. A., Coccorese, Vincenzo, Cocilovo, V., Coda, S., Coelho, R., Coenen, J., Coffey, I., Colas, L., Cole, M., Collins, S., Combs, S., Compan, J., Conboy, J. E., Conroy, S., Cook, N., Cook, S. P., Coombs, D., Cooper, S. R., Corre, Y., Corrigan, G., Cortes, S., Coster, D., Counsell, G. F., Courtois, X., Cox, M., Craciunescu, T., Cramp, S., Crisanti, F., Croft, O., Crombe, K., Crowley, B. J., Cruz, N., Cupido, L., Curuia, M., Cusack, R. A., Czarnecka, A., Dalley, S., Daly, E. T., Dalziel, A., Darrow, D., David, O., Davies, N., Davis, J. J., Day, I. E., Day, C., De Angelis, R., Dearcas, G., de Baar, M. R., Delacal, E., de la Luna, E., de Pablos, J. L., De Temmerman, G., DE TOMMASI, Gianmaria, de Vries, P. C., Degli Agostini, F., Delabie, E., del Castillo Negrete, D., Delpech, L., Denisov, G., Denyer, A. J., Denyer, R. F., Devaux, S., Devynck, P., Di Matteo, L., Dipace, L., Dirken, P. J., Dnestrovskiy, A., Dodt, D., Dominiczak, K., Dorling, S. E., Douai, D., Down, A. P., Doyle, P. T., Drake, J. R., Dreischuh, T., Drozdov, V., Dumortier, P., Dunai, D., Duran, I., Durodíe, F., Dylst, K., Eaton, R., Edlington, T., Edwards, A. M., Edwards, D. T., Edwards, P. K., Eich, T. h., Ekedahl, A., Elevant, T., Elfimov, A., Ellingboe, B., Elsmore, C. G., Emmoth, B., Ericsson, G., Eriksson, L. G., Eriksson, A., Esposito, B., Esser, H. G., Estrada, T., Evangelidis, E. A., Evans, G. E., Ewart, G. D., Ewers, D. T., Falchetto, G., Falie, D., Fanthome, J. G. A., Farina, D., Farthing, J. W., Fasoli, A., Faugeras, B., Fedorczak, N., Felton, R. C., Fenzi, C., Fernandes, H., Ferreira, J. A., Ferreira, J., Ferron, J., Fessey, J. A., Figini, L., Figueiredo, A., Figueiredo, J., Finburg, P., Finken, K. H., Fischer, U., Fitzgerald, N., Flanagan, J., Fleming, C., Fonseca, A., Forbes, A. D., Ford, O., Formisano, A., Fraboulet, D., Francis, R. J., Frassinetti, L., Fresa, R., Friconneau, J. P., Frigione, D., Fuchs, J. C., Fullard, K., Fundamenski, W., Furno Palumbo, M., Gafert, J., Ǵal, K., Galṽao, R., Garavaglia, S., Garbet, X., Garcia, J., Gar cia Munoz, M., Gardner, W., Garibaldi, P., Garnier, D., Garzotti, L., Gatu Johnson, M., Gaudio, P., Gauthier, E., Gaze, J. W., Gear, D. F., Gedney, J., Gee, S. J., Gelfusa, M., Genangeli, E., Gerasimov, S., Geraud, A., Gerbaud, T., Gherendi, M., Ghirelli, N., Giacalone, J. C., Giacomelli, L., Gibson, C. S., Gil, C., Gilligan, S. J., Gimblett, C. G., Gin, D., Giovannozzi, E., Giroud, C., Giruzzi, G., Glowacz, S., Godwin, J., Goff, J. K., Gohil, P., Goloborod’Ko, V., Gonçalves, B., Goniche, M., Gonzales, S., Gonźalezde Vicente, S. M., Goodyear, A., Gorelenkov, N., Gorini, G., Goulding, R., Graham, B., Graham, D., Graham, M. E., Granucci, G., Graves, J., Green, N. R., Greuner, H., Grigore, E., Griph, F. S., Grisolia, C., Gros, G., Grossetti, G., Groth, M., Gr̈unhagen, S., Gryaznevich, M. P., Guirlet, R., Gulejova, B., Gunn, J., Gupta, A., Guzdar, P., Hacek, P., Hackett, L. J., Hacquin, S., Haist, B., Hakola, A., Hall, S. J., Hallworthcook, S. P., Hamilton, D. T., Han, H., Handley, R. C., Harding, S., Harling, J. D. W., Harting, D., Harvey, M. J., Haupt, T. D. V., Havlickova, E., Hawkes, N. C., Hawryluk, R., Hay, J. H., Hayashi, N., Haydon, P. W., Hayward, I. R., Hazel, S., Heesterman, P. J. L., Heidbrink, W., Heikkinen, J., Hellesen, C., Hellsten, T., Hemming, O. N., Hender, T. C., Henderson, M., Hennig, C., Hennion, V., Hidalgo, C., Higashijima, S., Hill, J. W., Hill, M., Hill, K., Hillairet, J., Hillis, D., Hirai, T., Hitchin, M., Hobirk, J., Hogan, C., Hogben, C. H. A., Hogeweij, G. M. D., Hollingham, I. C., Holyaka, R., Homfray, D. A., Honeyands, G., Hong, S. H., Hopf, C., Horn, B. A., Horton, A. R., Horton, L. D., Hotchin, S. P., Hough, M. R., Houlberg, W., Howell, D. F., Hron, M., Huber, A., Huddleston, T. M., Hudson, Z., Hughes, M., Ḧuhnerbein, M., Hume, C. C., Hunt, A. J., Hunter, C. L., Hutchinson, T. S., Huygen, S., Huysmans, G., Hyn̈onen, V., Ide, S., Igreja, R., Illescas, C., Imbeaux, F., Ivanova, D., Ivings, E., Jachmich, S., Jackson, G., Jacquet, P., Jakubowska, K., Jakubowski, M., James, P. V., Jaspers, R. J. E., Jednorog, S., Jenkins, I., Jennison, M. A. C., Jeskins, C., Jin Kwon, O., Joffrin, E., Johnson, M. F., Johnson, R., Johnson, T., Jolovic, D., Jonauskas, V., Jones, E. M., Jones, G., Jones, H. D., Jones, T. T. C., Jouvet, M., Juṕen, C., Kachtchouk, I., Kaczmarczyk, J., Kallenbach, A., K̈allne, J., Kalupin, D., Ḱalvin, S., Kamelander, G., Kamendje, R., Kappatou, A., Karttunen, S., Kasparek, W., Katramados, I., Kaufmann, M., Kaveney, G., Kaye, A. S., Kear, M. J., Keeling, D. L., Kelliher, D., Kempenaars, M., Khilar, P., Kidd, N. G., Kiisk, M., Kim, K. M., King, R. F., Kinna, D. J., Kiptily, V., Kirnev, G., Kirneva, N., Kirov, K., Kirschner, A., Kisielius, R., Kislov, D., Kiss, G., Kiviniemi, T., Kizane, G., Klein, A., Klix, A., Knaup, M., Kneuper, K., Kneupner, H., Knight, P. J., Knipe, S. J., Kocan, M., K̈ochl, F., Kocsis, G., Konz, C., Koppitz, T., Korotkov, A., Koslowski, H. R., Kotov, V., Kovari, M. D., Kovarik, K., Kramer, G., Krasilnikov, A., Krasilnikov, V., Kraus, S., Kreter, A., Krieger, K., Kritz, A., Krivchenkov, Y., Kruezi, U., Krychowiak, M., Krylov, S., Ksiazek, I., Kubic, M., Kuhn, S., K̈uhnlein, W., Kurki Suonio, T., Kurowski, A., Kuteev, B., Kuyanov, A., La Haye, R., Laan, M., Labate, C., Lachichi, A., Lam, N., Lang, P., Large, M. T., Lassiwe, I., Last, J. R., Lawson, K. D., Laxåback, M., Layne, R. A., Lazzaro, E., Leguern, F., Leblanc, B., Leggate, H. J., Lehnen, M., Leigheb, M., Lengar, I., Lennholm, M., Lerche, E., Lescure, C. N., Li, Y., Li Puma, A., Liang, Y., Likonen, J., Lin, Y., Linke, J., Linstead, S. A., Lipshultz, B., Litaudon, X., Litvak, A. G., Liu, Y., Loarer, T., Loarte, A., Lobel, R. C., Lomas, P. J., Long, F. D., L̈onnroth, J., Looker, D. J., Lopez, J., Lotte, P. h., Loughlin, M. J., Loving, A. B., Lowry, C., Luce, T., Lucock, R. M. A., Lukanitsa, A., Lungu, A. M., Lungu, C. P., Lyssoivan, A., Macheta, P., Mackenzie, A. S., Macrae, M., Maddaluno, G., Maddison, G. P., Madsen, J., Maget, P., Maggi, C., Maier, H., Mailloux, J., Makowski, M., Manning, C. J., Mansfield, M., Manso, M. E., Mantica, P., Mantsinen, M., Maraschek, M., Marchetto, C., Marchitti, M. A., Mardenfeld, M., Marechal, J. L., Marinelli, M., Marinoni, A., Marinucci, M., M̈arki, J., Marocco, D., Marren, C. A., Martin, D., Martin, D. L., Martin, G., Martin, Y., Mart́ın Soĺıs, J. R., Masaki, K., Masiello, A., Maslov, M., Maszl, C., Matilal, A., Mattei, M., Matthews, G. F., Maviglia, F., May, C. R., Mayer, M., Mayoral, M. L., Mazon, D., Mazzotta, C., Mazzucato, E., Mccarthy, P., Mcclements, K. G., Mccormick, K., Mccullen, P. A., Mccune, D., Mcdonald, D. C., Mcgregor, R., Mckivitt, J. P., Meakins, A., Medina, F., Meigs, A. G., Menard, M., Meneses, L., Menmuir, S., Merrigan, I. R., Mertens, P. h., Messiaen, A., Meyer, H., Miano, Giovanni, Miele, M., Migliucci, P., Miller, A. G., Mills, S. F., Milnes, J. J., Min Kim, K., Mindham, T., Mirizzi, F., Mirones, E., Mironov, M., Mitteau, R., Mlynar, J., Mollard, P., Monakhov, I., Monier Garbet, P., Mooney, R., Moradi, S., Moreau, D., Moreau, P. h., Moreira, L., Morgan, A., Morgan, P. D., Morlock, C., Moro, A., Morris, A. W., Mort, G. L., Mrozek, C., Mueck, A., M̈uller, H. W., Murakami, M., Murari, A., Mustata, I., Nabais, F., Nardon, E., Nash, G., Naulin, V., Nave, M. F. F., Nazikian, R., Nedzelski, I., Negus, C. R., Neilson, J. D., Neto, A., Neu, R., Neubauer, O., Newbert, G. J., Newman, M., Nicholls, K. J., Nicolai, A., Nicolas, L., Nieckchen, P., Nielsen, P., Nielsen, A. H., Nielsen, S. K., Nielson, G., Nieto, J., Nightingale, M. P. S., Noble, C., Nocente, M., Nora, M., Nordman, H., Norman, M., Noterdaeme, J. M., Nowak, S., Nunes, I., Ognissanto, F., O’Gorman, T., Olariu, S., Oleynikov, A., O’Mullane, M., Ongena, J., Orsitto, F., Oswuigwe, O. I., Ottaviani, M., Oyama, N., Pacella, D., Paget, K., Palazzo, S., Pamela, J., Pamela, S., Panek, R., Pangione, L., Panin, A., Panis, T. h., Pankin, A., Pantea, A., Parail, V., Parisot, T. h., Parkin, A., Parsloe, A., Parsons, B. T., Pasqualotto, R., Pastor, P., Paterson, R., Paul, M. K., Peach, D., Pearce, R. J. H., Pearson, B. J., Pearson, I. J., Pedrick, L. C., Pedrosa, M. A., Pegourie, B., Pereira, R., Perelli Cippo, E., Pereverzev, G., Perevezentsev, A., Perezvonthun, C. h., Pericoli Ridolfini, V., Perona, A., Perrot, Y., Peruzzo, S., Peschanyy, S., Petravich, G., Petrizzi, L., Petrov, V., Petrzilka, V., Philipps, V., Piazza, G., Piccolo, F., Pietropaolo, A., Pillon, M., Pinches, S. D., Pinna, T., Pintsuk, G., Piovesan, P., Pironti, Alfredo, Pisano, F., Pitts, R., Plaum, B., Plyusnin, V., Polasik, M., Poli, F. M., Pomaro, N., Pompilian, O., Poncet, L., Pool, P. J., Popovichev, S., Porcelli, F., Porfiri, M. T., Portafaix, C., Pospieszczyk, A., Possnert, G., Prestopino, G., Prior, P., Prokopowicz, R., Proverbio, I., Pugno, R., Puiatti, M. E., Purahoo, K., Pustovitov, V., P̈utterich, T. h., P̈uttmann Kneupner, D., Quercia, Antonio, Rachlew, E., Rademaker, R., Rafiq, T., Rainford, M. S. J., Ramogida, G., Rantam̈aki, K., Rapp, J., Rasmussen, J. J., Ratt́a, G., Ravera, G., Reich, M., Reichle, R., Reiser, D., Reiss, R., Reiter, D., Rendell, D., Reux, C., Rewoldt, G., Ribeiro, T. T., Riccardo, V., Richards, D., Rigollet, F., Rimini, F. G., Rios, L., Riva, M., Roberts, J. E. C., Robins, R. J., Robinson, D. S., Robinson, S. A., Robson, D. W., Roche, H., R̈odig, M., Rodionov, N., Rohde, V., Rolfe, A., Romanelli, M., Romano, A., Romero, J., Ronchi, E., Rosanvallon, S., Roux, C. h., Rowe, S., Rubel, M., Rubinacci, Guglielmo, Ruchko, L., Ruiz, M., Ruset, C., Russell, M., Ruth, A., Ryc, L., Rydzy, A., Ryter, F., Rzadkiewicz, J., Saarelma, S., Sabathier, F., Sabot, R., Sadakov, S., Sagar, P., Saibene, G., Saille, A., Saint Laurent, F., Salmi, A., Salomaa, R., Salzedas, F., Samm, U., Sanchez, P., Sanders, S., Sanders, S. G., Sandford, G., Sandland, K., Sandquist, P., Sands, D. E. G., Santala, M. I. K., Sartori, F., Sartori, R., Sauter, O., Savelyev, A., Savtchkov, A., Scales, S. C., Scarabosio, A., Schaefer, N., Schlatter, C. h., Schmidt, V., Schmidt, A., Schmitz, O., Schmuck, S., Schneider, M., Scholz, M., Scḧopf, K., Schweer, B., Schweinzer, J., Scott, B., Seki, M., Semeraro, L., Semerok, A., Sergienko, G., Serra, F., Sertoli, M., Shannon, M. M. J., Sharapov, S. E., Shaw, S. R., Shevelev, A., Sievering, R., Silva, C. A., Simmons, P. A., Simonetto, A., Simpson, D., Sipila, S., Sips, A. C. C., Sirinelli, A., Sj̈ostrand, H., Skopintsev, D., K. S. l. a. b. k. o. w. s. k. a., Smith, P. G., Snipes, J., Snoj, L., Snyder, S., Soare, S., Solano, E. R., Soldatov, S., Soleto, A., Solomon, W., Soltane, C., Sonato, P., Sopplesa, A., Sorrentino, A., Sousa, J., Sowden, C. B. C., Sozzi, C., Sp̈ah, P., Spelzini, T., Spence, J., Spineanu, F., Spuig, P., Sẗabler, A., Stagg, R. D., Stamp, M. F., Stancalie, V., Stangeby, P., Stan Sion, C., Starkey, D. E., Stead, M. J., Stephen, A. V., Stevens, A. L., Stober, J., Stokes, R. B., Stork, D., Stoyanov, D., Strachan, J., Strand, P., Stransky, M., Strauss, D., Strintzi, D., Studholme, W., Suna, Y., Subba, F., Summers, H. P., Sun, Y., Surdu Bob, C., Surrey, E., Sutton, D. J., Svensson, J., Swain, D., Syme, B. D., Symonds, I. D., Szepesi, T., Szydlowski, A., Tabares, F., Takalo, V., Takenaga, H., Tala, T., Talbot, A. R., Taliercio, C., Tame, C., Tardini, G., Tardocchi, M., Taroni, L., Telesca, G., Terra, A., Terrington, A. O., Testa, D., Theis, J. M., Thomas, J. D., Thomas, P. D., Thomas, P. R., Thompson, V. K., Thomsen, H., Thomser, C., Thyagaraja, A., Tigwell, P. A., Tiseanu, I., Tivey, R., Todd, J. M., Todd, T. N., Tokar, M. Z., Tosti, S., Trabuc, P., Travere, J. M., Treutterer, W., Trimble, P., Trkov, A., Trukhina, E., Tsalas, M., Tsige Tamirat, H., Tsitrone, E., Tskhakaya jun, D., Tudisco, O., Tugarinov, S., Turner, M. M., Turri, G., Tyrrell, S. G. J., Umeda, N., Unterberg, B., Urano, H., Urquhart, A. J., Uytdenhouwen, I., Vaccaro, A., Vadgama, A. P., Vagliasindi, G., Valcarcel, D., Valisa, M., Vallory, J., Valovic, M., Van Eester, D., van Milligen, B., van Rooij, G. J., Varandas, C. A. F., Vartanian, S., Vdovin, V., Vega, J., Verdoolaege, G., Verger, J. M., Vermare, L., Verona, C., Versloot, T. h., Vervier, M., Vicente, J., Villari, S., Villedieu, E., Villone, F., Vince, J. E., Vine, G. J., Viola, B., Vitale, E., Vitelli, R., Vlad, M., Voitsekhovitch, I., Vrancken, M., Vulliez, K., Waldon, C. W. F., Walker, M., Walsh, M. J., Waterhouse, J., Watkins, M. L., Watson, M. J., Wauters, T., Way, M. W., Webb, C. R., Weiland, J., Weisen, H., Weiszflog, M., Wenninger, R., West, A. T., Weulersse, J. M., Weyssow, B., Wheatley, M. R., Whiteford, A. D., Whitehead, A. M., Whitehurst, A. G., Widdowson, A. M., Wieggers, R. C., Wiegmann, C., Wiesen, S., Wilson, A., Wilson, D., Wilson, D. J., Wilson, H. R., Wischmeier, M., Witts, D. M., Wolf, R. C., Wolowski, J., Woscov, P., Wright, G. M., Wright, J., G. S., Xu, Yavorskij, V., Yerashok, V., Yorkshades, J., Young, C., Young, D., Young, I. D., Yuhong, X., Zabeo, L., Zabolotsky, A., Zaccarian, L., Zagorski, R., Zaitsev, F. S., Zajac, S., Zakharov, L., Zanino, R., Zaroschi, V., Zastrow, K. D., Zatz, I., Zefran, B., Zeidner, W., Zerbini, M., Zhang, T., Zhu, Y., Zilli, E., Zimmermann, O., Zoita, V., Zoletnik, S., Zwingman, W., JET EFDA Contributors, Romanelli, F, Laxaback, M, Abel, I, Afanesyev, V, Agarici, G, Aggarwal, K, Airila, M, Akers, R, Alarcon, T, Albanese, R, Alexeev, A, Alfier, A, Allan, P, Almaviva, S, Alonso, A, Alonso, M, Alper, B, Altmann, H, Alves, D, Ambrosino, G, Amosov, V, Anda, G, Andersson, F, Andersson Sunden, E, Andreev, V, Andrew, Y, Angelone, M, Anghel, M, Anghel, A, Angioni, C, Apruzzese, G, Arcis, N, Arena, P, Argouarch, A, Ariola, M, Armitano, A, Armstrong, R, Arnoux, G, Arshad, S, Artaserse, G, Artaud, J, Ash, A, Asp, E, Asunta, O, Atanasiu, C, Atkins, G, Axton, M, Ayres, C, Baciero, A, Bailescu, V, Baiocchi, B, Baker, R, Balboa, I, Balorin, C, Balshaw, N, Banks, J, Baranov, Y, Barbier, D, Barlow, I, Barnard, M, Barnsley, R, Barrena, L, Barrera, L, Baruzzo, M, Basiuk, V, Bateman, G, Batiston, P, Baumgarten, N, Baylor, L, Bazylev, B, Beaumont, P, Beausang, K, Becoulet, M, Bekris, N, Beldishevski, M, Bell, A, Belli, F, Bellinger, M, Bellizio, T, Belo, P, Belonohy, E, Bennett, P, Benterman, N, Berger By, G, Bergsaker, H, Berk, H, Bernardo, J, Bertrand, B, Beurskens, M, Bieg, B, Bienkowska, B, Biewer, T, Bigi, M, Bilato, R, Bird, J, Bizarro, J, Blackman, T, Blanchard, P, Blanco, E, Blum, J, Bobkov, V, Boboc, A, Boilson, D, Bolshakova, I, Bolzonella, T, Boncagni, L, Bonheure, G, Bonnin, X, Borba, D, Borthwick, A, Botrugno, A, Boulbe, C, Bouquey, F, Bourdelle, C, Bovert, K, Bowden, M, Boyce, T, Boyer, H, Bozhenkov, A, Brade, R, Bradshaw, J, Braet, J, Braic, V, Braithwaite, G, Brault, C, Braune, H, Breizman, B, Bremond, S, Brennan, P, Brett, A, Breue, J, Brezinsek, S, Bright, M, Briscoe, F, Brix, M, Brombin, M, Brown, B, Brown, D, Bruschi, A, Brzozowski, J, Bucalossi, J, Buckley, M, Budd, T, Budny, R, Bunting, P, Buratti, P, Burcea, G, Butcher, P, Buttery, R, Cacao, R, Calabro, G, Callaghan, C, Caminade, J, Camp, P, Campling, D, Canik, J, Cannas, B, Capel, A, Carannante, G, Card, P, Cardinali, A, Carlstrom, T, Carman, P, Carralero, D, Carraro, L, Carter, T, Carvalho, B, Carvalho, P, Casati, A, Castaldo, C, Caughman, J, Cavazzana, R, Cavinato, M, Cecconello, M, Cecil, F, Cenedese, A, Centioli, C, Cesario, R, Challis, C, Chandler, M, Chang, C, Chankin, A, Chapman, I, Child, D, Chiru, P, Chitarin, G, Chugonov, I, Ciric, D, Clairet, F, Clarke, R, Clay, R, Clever, M, Coad, J, Coates, P, Coccorese, V, Cocilovo, V, Coda, S, Coelho, R, Coenen, J, Coffey, I, Colas, L, Cole, M, Collins, S, Combs, S, Compan, J, Conboy, J, Conroy, S, Cook, N, Cook, S, Coombs, D, Cooper, S, Corre, Y, Corrigan, G, Cortes, S, Coster, D, Counsell, G, Courtois, X, Cox, M, Craciunescu, T, Cramp, S, Crisanti, F, Croft, O, Crombe, K, Crowley, B, Cruz, N, Cupido, L, Curuia, M, Cusack, R, Czarnecka, A, Dalley, S, Daly, E, Dalziel, A, Darrow, D, David, O, Davies, N, Davis, J, Day, I, Day, C, De Angelis, R, de Arcas, G, de Baar, M, de la Cal, E, de la Luna, E, de Pablos, J, De Temmerman, G, De Tommasi, G, de Vries, P, Degli Agostini, F, Delabie, E, del Castillo Negrete, D, Delpech, L, Denisov, G, Denyer, A, Denyer, R, Devaux, S, Devynck, P, Di Matteo, L, Di Pace, L, Dirken, P, Dnestrovskiy, A, Dodt, D, Dominiczak, K, Dorling, S, Douai, D, Down, A, Doyle, P, Drake, J, Dreischuh, T, Drozdov, V, Dumortier, P, Dunai, D, Duran, I, Durodie, F, Dylst, K, Eaton, R, Edlington, T, Edwards, A, Edwards, D, Edwards, P, Eich, T, Ekedahl, A, Elevant, T, Elfimov, A, Ellingboe, B, Elsmore, C, Emmoth, B, Ericsson, G, Eriksson, L, Eriksson, A, Esposito, B, Esser, H, Estrada, T, Evangelidis, E, Evans, G, Ewart, G, Ewers, D, Falchetto, G, Falie, D, Fanthome, J, Farina, D, Farthing, J, Fasoli, A, Faugeras, B, Fedorczak, N, Felton, R, Fenzi, C, Fernandes, H, Ferreira, J, Ferron, J, Fessey, J, Figini, L, Figueiredo, A, Figueiredo, J, Finburg, P, Finken, K, Fischer, U, Fitzgerald, N, Flanagan, J, Fleming, C, Fonseca, A, Forbes, A, Ford, O, Formisano, A, Fraboulet, D, Francis, R, Frassinetti, L, Fresa, R, Friconneau, J, Frigione, D, Fuchs, J, Fullard, K, Fundamenski, W, Furno Palumbo, M, Gafert, J, Gal, K, Galvao, R, Garavaglia, S, Garbet, X, Garcia, J, Garcia Munoz, M, Gardner, W, Garibaldi, P, Garnier, D, Garzotti, L, Gatu Johnson, M, Gaudio, P, Gauthier, E, Gaze, J, Gear, D, Gedney, J, Gee, S, Gelfusa, M, Genangeli, E, Gerasimov, S, Geraud, A, Gerbaud, T, Gherendi, M, Ghirelli, N, Giacalone, J, Giacomelli, L, Gibson, C, Gil, C, Gilligan, S, Gimblett, C, Gin, D, Giovannozzi, E, Giroud, C, Giruzzi, G, Glowacz, S, Godwin, J, Goff, J, Gohil, P, Goloborod'Ko, V, Goncalves, B, Goniche, M, Gonzales, S, Gonzales de Vicente, S, Goodyear, A, Gorelenkov, N, Gorini, G, Goulding, R, Graham, B, Graham, D, Graham, M, Granucci, G, Graves, J, Green, N, Greuner, H, Grigore, E, Griph, F, Grisolia, C, Gros, G, Grossetti, G, Groth, M, Gruenhagen, S, Gryaznevich, M, Guirlet, R, Gulejova, B, Gunn, J, Gupta, A, Guzdar, P, Hacek, P, Hackett, L, Hacquin, S, Haist, B, Hakola, A, Hall, S, Hallworth Cook, S, Hamilton, D, Han, H, Handley, R, Harding, S, Harling, J, Harting, D, Harvey, M, Haupt, T, Havlickova, E, Hawkes, N, Hawryluk, R, Hay, J, Hayashi, N, Haydon, P, Hayward, I, Hazel, S, Heesterman, P, Heidbrink, W, Heikkinen, J, Hellesen, C, Hellsten, T, Hemming, O, Hender, T, Henderson, M, Hennig, C, Hennion, V, Hidalgo, C, Higashijima, S, Hill, J, Hill, M, Hill, K, Hillairet, J, Hillis, D, Hirai, T, Hitchin, M, Hobirk, J, Hogan, C, Hogben, C, Hogeweij, G, Hollingham, I, Holyaka, R, Homfray, D, Honeyands, G, Hong, S, Hopf, C, Horn, B, Horton, A, Horton, L, Hotchin, S, Hough, M, Houlberg, W, Howell, D, Hron, M, Huber, A, Huddleston, T, Hudson, Z, Hughes, M, Huehnerbein, M, Hume, C, Hunt, A, Hunter, C, Hutchinson, T, Huygen, S, Huysmans, G, Hynoenen, V, Ide, S, Igreja, R, Illescas, C, Imbeaux, F, Ivanova, D, Ivings, E, Jachmich, S, Jackson, G, Jacquet, P, Jakubowska, K, Jakubowski, M, James, P, Jaspers, R, Jednorog, S, Jenkins, I, Jennison, M, Jeskins, C, Jin Kwon, O, Joffrin, E, Johnson, M, Johnson, R, Johnson, T, Jolovic, D, Jonauskas, V, Jones, E, Jones, G, Jones, H, Jones, T, Jouvet, M, Jupen, C, Kachtchouk, I, Kaczmarczyk, J, Kallenbach, A, Kaellne, J, Kalupin, D, Kalvin, S, Kamelander, G, Kamendje, R, Kappatou, A, Karttunen, S, Kasparek, W, Katramados, I, Kaufmann, M, Kaveney, G, Kaye, A, Kear, M, Keeling, D, Kelliher, D, Kempenaars, M, Khilar, P, Kidd, N, Kiisk, M, Kim, K, King, R, Kinna, D, Kiptily, V, Kirnev, G, Kirneva, N, Kirov, K, Kirschner, A, Kisielius, R, Kislov, D, Kiss, G, Kiviniemi, T, Kizane, G, Klein, A, Klix, A, Knaup, M, Kneuper, K, Kneupner, H, Knight, P, Knipe, S, Kocan, M, Koechl, F, Kocsis, G, Konz, C, Koppitz, T, Korotkov, A, Koslowski, H, Kotov, V, Kovari, M, Kovarik, K, Kramer, G, Krasilnikov, A, Krasilnikov, V, Kraus, S, Kreter, A, Krieger, K, Kritz, A, Krivchenkov, Y, Kruezi, U, Krychowiak, M, Krylov, S, Ksiazek, I, Kubic, M, Kuhn, S, Kuehnlein, W, Kurki Suonio, T, Kurowski, A, Kuteev, B, Kuyanov, A, La Haye, R, Laan, M, Labate, C, Lachichi, A, Lam, N, Lang, P, Large, M, Lassiwe, I, Last, J, Lawson, K, Layne, R, Lazzaro, E, Le Guern, F, Leblanc, B, Leggate, H, Lehnen, M, Leigheb, M, Lengar, I, Lennholm, M, Lerche, E, Lescure, C, Li, Y, Li Puma, A, Liang, Y, Likonen, J, Lin, Y, Linke, J, Linstead, S, Lipshultz, B, Litaudon, X, Litvak, A, Liu, Y, Loarer, T, Loarte, A, Lobel, R, Lomas, P, Long, F, Loennroth, J, Looker, D, Lopez, J, Lotte, P, Loughlin, M, Loving, A, Lowry, C, Luce, T, Lucock, R, Lukanitsa, A, Lungu, A, Lungu, C, Lyssoivan, A, Macheta, P, Mackenzie, A, Macrae, M, Maddaluno, G, Maddison, G, Madsen, J, Maget, P, Maggi, C, Maier, H, Mailloux, J, Makowski, M, Manning, C, Mansfield, M, Manso, M, Mantica, P, Mantsinen, M, Maraschek, M, Marchetto, C, Marchitti, M, Mardenfeld, M, Marechal, J, Marinelli, M, Marinoni, A, Marinucci, M, Maerki, J, Marocco, D, Marren, C, Martin, D, Martin, G, Martin, Y, Martin Solis, J, Masaki, K, Masiello, A, Maslov, M, Maszl, C, Matilal, A, Mattei, M, Matthews, G, Maviglia, F, May, C, Mayer, M, Mayoral, M, Mazon, D, Mazzotta, C, Mazzucato, E, Mccarthy, P, Mcclements, K, Mccormick, K, Mccullen, P, Mccune, D, Mcdonald, D, Mcgregor, R, Mckivitt, J, Meakins, A, Medina, F, Meigs, A, Menard, M, Meneses, L, Menmuir, S, Merrigan, I, Mertens, P, Messiaen, A, Meyer, H, Miano, G, Miele, M, Migliucci, P, Miller, A, Mills, S, Milnes, J, Min Kim, K, Mindham, T, Mirizzi, F, Mirones, E, Mironov, M, Mitteau, R, Mlynar, J, Mollard, P, Monakhov, I, Monier Garbet, P, Mooney, R, Moradi, S, Moreau, D, Moreau, P, Moreira, L, Morgan, A, Morgan, P, Morlock, C, Moro, A, Morris, A, Mort, G, Mrozek, C, Mueck, A, Mueller, H, Murakami, M, Murari, A, Mustata, I, Nabais, F, Nardon, E, Nash, G, Naulin, V, Nave, M, Nazikian, R, Nedzelski, I, Negus, C, Neilson, J, Neto, A, Neu, R, Neubauer, O, Newbert, G, Newman, M, Nicholls, K, Nicolai, A, Nicolas, L, Nieckchen, P, Nielsen, P, Nielsen, A, Nielsen, S, Nielson, G, Nieto, J, Nightingale, M, Noble, C, Nocente, M, Nora, M, Nordman, H, Norman, M, Noterdaeme, J, Nowak, S, Nunes, I, Ognissanto, F, O'Gorman, T, Olariu, S, Oleynikov, A, O'Mullane, M, Ongena, J, Orsitto, F, Oswuigwe, O, Ottaviani, M, Oyama, N, Pacella, D, Paget, K, Palazzo, S, Pamela, J, Pamela, S, Panek, R, Pangione, L, Panin, A, Panis, T, Pankin, A, Pantea, A, Parail, V, Parisot, T, Parkin, A, Parsloe, A, Parsons, B, Pasqualotto, R, Pastor, P, Paterson, R, Paul, M, Peach, D, Pearce, R, Pearson, B, Pearson, I, Pedrick, L, Pedrosa, M, Pegourie, B, Pereira, R, Perelli Cippo, E, Pereverzev, G, Perevezentsev, A, Perez von Thun, C, Pericoli Ridolfini, V, Perona, A, Perrot, Y, Peruzzo, S, Peschanyy, S, Petravich, G, Petrizzi, L, Petrov, V, Petrzilka, V, Philipps, V, Piazza, G, Piccolo, F, Pietropaolo, A, Pillon, M, Pinches, S, Pinna, T, Pintsuk, G, Piovesan, P, Pironti, A, Pisano, F, Pitts, R, Plaum, B, Plyusnin, V, Polasik, M, Poli, F, Pomaro, N, Pompilian, O, Poncet, L, Pool, P, Popovichev, S, Porcelli, F, Porfiri, M, Portafaix, C, Pospieszczyk, A, Possnert, G, Prestopino, G, Prior, P, Prokopowicz, R, Proverbio, L, Pugno, R, Puiatti, M, Purahoo, K, Pustovitov, V, Puetterich, T, Puettmann Kneupner, D, Quercia, A, Rachlew, E, Rademaker, R, Rafiq, T, Rainford, M, Ramogida, G, Rantamaeki, K, Rapp, J, Rasmussen, J, Ratta, G, Ravera, G, Reich, M, Reichle, R, Reiser, D, Reiss, R, Reiter, D, Rendell, D, Reux, C, Rewoldt, G, Ribeiro, T, Riccardo, V, Richards, D, Rigollet, F, Rimini, F, Rios, L, Riva, M, Roberts, J, Robins, R, Robinson, D, Robinson, S, Robson, D, Roche, H, Roedig, M, Rodionov, N, Rohde, V, Rolfe, A, Romanelli, M, Romano, A, Romero, J, Ronchi, E, Rosanvallon, S, Roux, C, Rowe, S, Rubel, M, Rubinacci, G, Ruchko, L, Ruiz, M, Ruset, C, Russell, M, Ruth, A, Ryc, L, Rydzy, A, Ryter, F, Rzadkiewicz, J, Saarelma, S, Sabathier, F, Sabot, R, Sadakov, S, Sagar, P, Saibene, G, Saille, A, Saint Laurent, F, Salmi, A, Salomaa, R, Salzedas, F, Samm, U, Sanchez, P, Sanders, S, Sandford, G, Sandland, K, Sandquist, P, Sands, D, Santala, M, Sartori, F, Sartori, R, Sauter, O, Savelyev, A, Savtchkov, A, Scales, S, Scarabosio, A, Schaefer, N, Schlatter, C, Schmidt, V, Schmidt, A, Schmitz, O, Schmuck, S, Schneider, M, Scholz, M, Schoepf, K, Schweer, B, Schweinzer, J, Scott, B, Seki, M, Semeraro, L, Semerok, A, Sergienko, G, Serra, F, Sertoli, M, Shannon, M, Sharapov, S, Shaw, S, Shevelev, A, Sievering, R, Silva, C, Simmons, P, Simonetto, A, Simpson, D, Sipila, S, Sips, A, Sirinelli, A, Sjoestrand, H, Skopintsev, D, Slabkowska, K, Smith, P, Snipes, J, Snoj, L, Snyder, S, Soare, S, Solano, E, Soldatov, S, Soleto, A, Solomon, W, Soltane, C, Sonato, P, Sopplesa, A, Sorrentino, A, Sousa, J, Sowden, C, Sozzi, C, Spaeh, P, Spelzini, T, Spence, J, Spineanu, F, Spuig, P, Staebler, A, Stagg, R, Stamp, M, Stancalie, V, Stangeby, P, Stan Sion, C, Starkey, D, Stead, M, Stephen, A, Stevens, A, Stober, J, Stokes, R, Stork, D, Stoyanov, D, Strachan, J, Strand, P, Stransky, M, Strauss, D, Strintzi, D, Studholme, W, Su Na, Y, Subba, F, Summers, H, Sun, Y, Surdu Bob, C, Surrey, E, Sutton, D, Svensson, J, Swain, D, Syme, B, Symonds, I, Szepesi, T, Szydlowski, A, Tabares, F, Takalo, V, Takenaga, H, Tala, T, Talbot, A, Taliercio, C, Tame, C, Tardini, G, Tardocchi, M, Taroni, L, Telesca, G, Terra, A, Terrington, A, Testa, D, Theis, J, Thomas, J, Thomas, P, Thompson, V, Thomsen, H, Thomser, C, Thyagaraja, A, Tigwell, P, Tiseanu, I, Tivey, R, Todd, J, Todd, T, Tokar, M, Tosti, S, Trabuc, P, Travere, J, Treutterer, W, Trimble, P, Trkov, A, Trukhina, E, Tsalas, M, Tsige Tamirat, H, Tsitrone, E, Tskhakaya, D, Tudisco, O, Tugarinov, S, Turner, M, Turri, G, Tyrrell, S, Umeda, N, Unterberg, B, Urano, H, Urquhart, A, Uytdenhouwen, I, Vaccaro, A, Vadgama, A, Vagliasindi, G, Valcarcel, D, Valisa, M, Vallory, J, Valovic, M, Van Eester, D, van Milligen, B, van Rooij, G, Varandas, C, Vartanian, S, Vdovin, V, Vega, J, Verdoolaege, G, Verger, J, Vermare, L, Verona, C, Versloot, T, Vervier, M, Vicente, J, Villari, S, Villedieu, E, Villone, F, Vince, J, Vine, G, Viola, B, Vitale, E, Vitelli, R, Vlad, M, Voitsekhovitch, I, Vrancken, M, Vulliez, K, Waldon, C, Walker, M, Walsh, M, Waterhouse, J, Watkins, M, Watson, M, Wauters, T, Way, M, Webb, C, Weiland, J, Weisen, H, Weiszflog, M, Wenninger, R, West, A, Weulersse, J, Weyssow, B, Wheatley, M, Whiteford, A, Whitehead, A, Whitehurst, A, Widdowson, A, Wieggers, R, Wiegmann, C, Wiesen, S, Wilson, A, Wilson, D, Wilson, H, Wischmeier, M, Witts, D, Wolf, R, Wolowski, J, Woscov, P, Wright, G, Wright, J, Xu, G, Yavorskij, V, Yerashok, V, Yorkshades, J, Young, C, Young, D, Young, I, Yuhong, X, Zabeo, L, Zabolotsky, A, Zaccarian, L, Zagorski, R, Zaitsev, F, Zajac, S, Zakharov, L, Zanino, R, Zaroschi, V, Zastrow, K, Zatz, I, Zefran, B, Zeidner, W, Zerbini, M, Zhang, T, Zhu, Y, Zilli, E, Zimmermann, O, Zoita, V, Zoletnik, S, Zwingman, W, Correction Romanelli, F, Albanese, R., Ambrosino, G., Andersson Sundén, E., Bécoulet, M., Bellizio, T., Belonohy, É., Bovert, K. V., Cação, R., Calabró, G., Carannante, G., Coccorese, V., De Arcas, G., De Baar, M. R., De La Cal, E., De La Luna, E., De Pablos, J. L., De Tommasi, G., De Vries, P. C., Del Castillo Negrete, D., Di Pace, L., Durodié, F., Formisano, Alessandro, Gál, K., Galvão, R., Garcia Munoz, M., Goloborod'Ko, V., Gonçalves, B., González De Vicente, S. M., Grünhagen, S., Hallworth Cook, S. P., Hühnerbein, M., Hynönen, V., Jupén, C., Källne, J., Kálvin, S., Köchl, F., Kühnlein, W., Le Guern, F., Lönnroth, J., Märki, J., Martín Solís, J. R., Mattei, Massimiliano, Miano, G., Müller, H. W., O'Gorman, T., O'Mullane, M., Perez Von Thun, C. h., Pironti, A., Pütterich, T. h., Püttmann Kneupner, D., Quercia, A., Rantamäki, K., Rattá, G., Rödig, M., Rubinacci, G., Schöpf, K., Sjöstrand, H., Slabkowska, K., Späh, P., Stäbler, A., Su Na, Y., Tskhakaya Jun, D., Van Milligen, B., Van Rooij, G. J., Xu, G. S., Faculdade de Engenharia, Kamendjea, R., Alarcon, Th., Andersson-Sundén, E., Andrew, P. L., Argouach, A., Balbao, I., Berger-By, G., Bergkvist, T., Coutois, X., David, E., De-Angelis, R., Del-Castillo-Negrete, D., De-Tommasi, G., Deveaux, S., Eich, Th., Erents, S. K., Gatu-Johnson, M., Holmström, K., Kurki-Suonio, T., Lauro Taroni, L., Laxaback, M., Liu, Y. Q., Llewellyn Smith, C., Maviglia, A., Mertens, Ph., Monier-Garbet, P., Moreau, Ph., Norris, C., Noterdaeme, J. -M., Paméla, J., Panis, Th., Parisot, Th., Perez Von Thun, C., Perez Von Thun, Ch., Pericoli-Ridolfini, V., Phillips, V., Pütterich, Th., Püttmann-Kneupner, D., Roux, Ch., Saint-Laurent, F., Schlatter, Ch., Sundelin, P., Surdu-Bob, C., Hompson, V. K., Tsige-Tamirat, H., Tskhakaya, D., Uytdenhoven, I., Versloot, Th., Villedieux, E., Walden, A. D., Paméla, J, and Jet, C
- Subjects
Nuclear and High Energy Physics ,52.55.Fa Tokamaks, spherical tokamak ,Materials science ,Tokamak ,Physics and Astronomy (all) ,Condensed Matter Physics ,Física [Ciências exactas e naturais] ,Cyclotron ,law.invention ,Bootstrap current ,Physical sciences [Natural sciences] ,law ,Physics::Plasma Physics ,ITER ,divertor ,FIS/03 - FISICA DELLA MATERIA ,Nuclear and High Energy Physic ,Jet (fluid) ,Safety factor ,Divertor ,52.50.Qt Plasma heating by radio-frequency field ,Settore FIS/01 - Fisica Sperimentale ,magnetic confinement ,Magnetic confinement fusion ,Física ,52.55.Rk Power exhaust ,JET, overview ,Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin) ,Computational physics ,Physical sciences ,ICR, ICP, helicons ,___ ,JET ,Beta (plasma physics) ,Atomic physics ,tokamaks - Abstract
Since the last IAEA conference, the scientific programme of JET has focused on the qualification of the integrated operating scenarios for ITER and on physics issues essential for the consolidation of design choices and the efficient exploitation of ITER. Particular attention has been given to the characterization of the edge plasma, pedestal energy and edge localized modes (ELMs), and their impact on plasma facing components (PFCs). Various ELM mitigation techniques have been assessed for all ITER operating scenarios using active methods such as resonant magnetic field perturbation, rapid variation of the radial field and pellet pacing. In particular, the amplitude and frequency of type I ELMs have been actively controlled over a wide parameter range (q(95) = 3-4.8, beta(N)
356. MHD instabilities
- Author
-
Bateman, G
- Published
- 1978
357. Ripple reduction poloidal field coils for tokamak fusion reactors
- Author
-
Bateman, G
- Published
- 1981
358. MHD-instabilities as an initial-value problem for elongated cross sections
- Author
-
Bateman, G
- Published
- 1975
359. Plasma transport in a Compact Ignition Tokamak
- Author
-
Bateman, G
- Published
- 1988
360. Mapping from rectangular to harmonic representation
- Author
-
Bateman, G
- Published
- 1987
- Full Text
- View/download PDF
361. Inductive effects in flux conserving tokamaks
- Author
-
Bateman, G
- Published
- 1979
- Full Text
- View/download PDF
362. Tokamak Fusion Test Reactor central ignition scenarios
- Author
-
Bateman, G
- Published
- 1988
363. LONG-WAVELENGTH ION-ACOUSTIC WAVES.
- Author
-
Bateman, G
- Published
- 1972
- Full Text
- View/download PDF
364. DAMPING OF ELECTRON PLASMA OSCILLATIONS IN A UNIFORM ELECTRIC FIELD.
- Author
-
Bateman, G
- Published
- 1972
- Full Text
- View/download PDF
365. TRANS-SPHENOIDAL HYPOPHYSECTOMY
- Author
-
Bateman, G
- Published
- 1964
366. Energy principle with specific inductance
- Author
-
Bateman, G
- Published
- 1973
- Full Text
- View/download PDF
367. Slab models for classical diffusion in the belt pinch
- Author
-
Bateman, G
- Published
- 1973
- Full Text
- View/download PDF
368. Saturated tearing modes in tokamaks with divertors
- Author
-
Bateman, G
- Published
- 1982
369. ENERGY PRINCIPLE WITH SPECIFIC INDUCTANCE.
- Author
-
Bateman, G
- Published
- 1971
370. Survival rate and complication-free survival rate of implant-retained prostheses in the oral rehabilitation of patients with head and neck cancer: A retrospective evaluation of a cohort from a regional service.
- Author
-
Laverty DP, Addison O, Sharma P, Newsum D, and Bateman G
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Aged, Dental Restoration Failure, Adult, Aged, 80 and over, Mouth Rehabilitation methods, Survival Rate, Dental Prosthesis, Implant-Supported, Head and Neck Neoplasms complications
- Abstract
Statement of Problem: Literature reporting on the prosthetic survival and complications of implant-retained prostheses in patients with head and neck cancer is sparse., Purpose: The purpose of this retrospective study was to present the survival rates and complication-free survival rates of both fixed and removable implant-retained oral prostheses in patients with head and neck cancer while also reporting on the frequency and causes of failure and complications for each prosthesis type., Material and Methods: A retrospective analysis of the prosthetic survival rates and complication-free survival rates of implant-retained oral prostheses and the frequency and causes of failure and complications in patients with head and neck cancer treated in a regional unit from 2012 to 2017 was performed. Differences in categorical and continuous data were assessed for statistical significance by using the Pearson chi-squared test, Fisher exact test, t test, and analysis of variance as appropriate. Cox proportional hazard regression models were fitted to evaluate the association between prostheses type, clinical and medical factors, and the outcomes of survival and complication-free survival. Descriptive statistics were used to analyze the frequency and type of prosthetic complications., Results: The sample was composed of 153 patients diagnosed with head and neck cancer who had completed implant-retained prosthodontic rehabilitation and had been provided with 221 prostheses. The 5-year survival rate was 87% for maxillary fixed prostheses, 79% for mandibular fixed, 66% for maxillary removable, and 50% for mandibular removable. Hazard ratios were calculated showing that the 5-year survival rate of a mandibular removable prosthesis (HR=5.1; 95% CI 1.60-16.25) (P=.006) was greater than that of a maxillary fixed prosthesis (HR=1.0). The 5-year complication-free survival rate was highest for mandibular fixed prostheses (62%), followed by maxillary fixed (58%), maxillary removable (36%), and mandibular removable prostheses (29%). Hazard ratios showed that the 5-year survival rate of maxillary removable (HR=1.91; 95% CI 1.01-3.66) (P=.048) and mandibular removable prosthesis (HR=2.29; 95% CI 1.23-4.25) (P=.009) was greater than that of a maxillary fixed prosthesis (HR=1.0). Variables of radiotherapy, grafting, age, and sex and their influence on the survival rate and complication-free survival rate were assessed but were not statistically significant., Conclusions: This evaluation indicated that fixed implant-retained prostheses had a higher 5-year survival rate and 5-year complication-free survival rate than removable implant-retained prostheses in patients with head and neck cancer., (Copyright © 2022 Editorial Council for the Journal of Prosthetic Dentistry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
371. Spaceflight-Associated Neuro-Ocular Syndrome and Idiopathic Intracranial Hypertension: Can Anemia and Hyperemia Underlie Both?
- Author
-
Bateman GA and Bateman AR
- Subjects
- Humans, Syndrome, Weightlessness adverse effects, Vision Disorders, Hyperemia diagnostic imaging, Pseudotumor Cerebri diagnostic imaging, Pseudotumor Cerebri complications, Space Flight, Anemia etiology
- Published
- 2024
- Full Text
- View/download PDF
372. Clinical significance of cement leakage in kyphoplasty and vertebroplasty: a systematic review.
- Author
-
Rose LD, Bateman G, and Ahmed A
- Subjects
- Humans, Fractures, Compression surgery, Spinal Fractures surgery, Postoperative Complications etiology, Postoperative Complications epidemiology, Clinical Relevance, Kyphoplasty adverse effects, Kyphoplasty methods, Bone Cements adverse effects, Vertebroplasty adverse effects, Vertebroplasty methods, Osteoporotic Fractures surgery
- Abstract
Background: Osteoporotic vertebral compression fractures affect a large number of elderly people and cause significant issues with pain and mobility. Percutaneous vertebroplasty (PVP) and kyphoplasty (PKP) are employed to treat those who remain symptomatic, with comparable clinical outcomes. Although PVP is faster and less expensive, concerns around cement-leakage complications make PKP perceptively safer., Methods: By means of systematic review, we sought to ascertain whether PVP did carry a higher risk of cement-leakage and associated symptomatic complications (neural compromise, pulmonary embolism and need for emergency decompression surgery)., Results: Our search of 138 articles returned six studies after shortlisting and manual review: three randomised-controlled trials, and three retrospective comparative studies which met our criteria and directly compared cement-leakage rates and complications between the two treatments. 532 PVPs and 493 PKPs recorded 213 (39.3%) and 143 (28.9%) leaks, respectively (p < 0.0005). Of these, no leaks resulted in any of the aforementioned leak-related complications. No meta-analysis was performed due to heterogeneity of the data., Conclusions: We therefore concluded that whilst PVP does result in more cement leaks, this does not appear to be clinically significant. Further studies would add weight to this conclusion, and cost-effectiveness should be assessed to restore confidence in PVP., Level of Evidence: Level III Evidence., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
373. Consensus statement for the management of incidentally found brain white matter hyperintensities in general medical practice.
- Author
-
Ottavi TP, Pepper E, Bateman G, Fiorentino M, and Brodtmann A
- Subjects
- Adult, Humans, Brain diagnostic imaging, Aging, White Matter diagnostic imaging, Stroke, General Practitioners
- Abstract
Introduction: There is a paradigm shift in our understanding of white matter hyperintensities (WMH) found on brain imaging. They were once thought to be a normal phenomenon of ageing and, therefore, warranted no further investigation. However, evidence now suggests these lesions are markers of poor brain and cardiovascular health, portending an increased risk of stroke, cognitive decline, depression and death. Nevertheless, no specific guidelines exist for the management of incidentally found WMH for general medical practitioners and other clinicians ordering brain magnetic resonance imaging scans for diverse clinical indications. Informed by a literature review and expert opinion gleaned from stroke neurologists, medical and imaging specialists, and general practitioners, we present our consensus statement to guide the management of incidentally found WMH in adults., Main Recommendations: When incidental WMH are found on brain imaging: Perform a detailed history and examination to screen for neurological events. Investigate for potential undiagnosed or undertreated cardiovascular risk factors, especially hypertension and diabetes mellitus. Commence intensive and individualised cardiovascular risk management when risk factors are uncovered. Treat underlying risk factors via accepted guidelines but note that antiplatelet and anticoagulant medications should not be prescribed for incidental WMH in the absence of an alternative indication., Changes to Management as a Result of This Consensus Statement: A brain health opportunity. We consider the discovery of incidental WMH on brain imaging to represent an opportunity to investigate for common cardiovascular risk factors and to optimise brain health. This can be commenced and monitored by the general practitioner or physician without delay in waiting for an outpatient neurology review., (© 2023 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
374. Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis.
- Author
-
Bateman G, Guo-Parke H, Rodgers AM, Linden D, Bailey M, Weldon S, Kidney JC, and Taggart CC
- Abstract
Cellular senescence is a state of permanent cell cycle arrest triggered by various intrinsic and extrinsic stressors. Cellular senescence results in impaired tissue repair and remodeling, loss of physiological integrity, organ dysfunction, and changes in the secretome. The systemic accumulation of senescence cells has been observed in many age-related diseases. Likewise, cellular senescence has been implicated as a risk factor and driving mechanism in chronic obstructive pulmonary disease (COPD) pathogenesis. Airway epithelium exhibits hallmark features of senescence in COPD including activation of the p53/p21WAF1/CIP1 and p16INK4A/RB pathways, leading to cell cycle arrest. Airway epithelial senescent cells secrete an array of inflammatory mediators, the so-called senescence-associated secretory phenotype (SASP), leading to a persistent low-grade chronic inflammation in COPD. SASP further promotes senescence in an autocrine and paracrine manner, potentially contributing to the onset and progression of COPD. In addition, cellular senescence in COPD airway epithelium is associated with telomere dysfunction, DNA damage, and oxidative stress. This review discusses the potential mechanisms of airway epithelial cell senescence in COPD, the impact of cellular senescence on the development and severity of the disease, and highlights potential targets for modulating cellular senescence in airway epithelium as a potential therapeutic approach in COPD.
- Published
- 2023
- Full Text
- View/download PDF
375. Investigating the hemodynamic implications of triangular cross-sectioned superior sagittal sinus vessels and the errors associated with idealised modelling.
- Author
-
Robert Bateman A, Alexander Bateman G, and Barber T
- Subjects
- Humans, Veins, Hydrodynamics, Stress, Mechanical, Superior Sagittal Sinus, Hemodynamics
- Abstract
The superior sagittal sinus (SSS) is a blood vessel that is often observed to be approximately triangular in cross-section, due to how the venous wall attaches to the surrounding tissue. Despite this, the vessel has been assumed to be circular, when models are generated without patient-specific data. In this study, the differences between the cerebral hemodynamics of one circular, three triangular and five patient-specific cross-sectional models of a SSS were conducted. The errors associated with using circular cross-sectioned flow extensions were also determined. Computational fluid dynamics (CFD) models were generated from these geometries, with a population mean transient blood flow profile incorporated. The maximal helicity of the fluid flow was found to be elevated in the triangular cross-section, compared to the circular, with a higher wall shear stress (WSS) observed over a smaller, more concentrated region on the posterior sinus wall. The errors associated with using a circular cross-section were detailed, with the cross-sectional area appearing to have a greater influence on the hemodynamic parameters than the triangularity or circularity of the cross-section. This highlighted the importance of exhibiting caution when incorporating idealised modelling, especially when commenting on the true hemodynamics of these models. Errors were also found to be induced when using a circular cross-sectioned flow extension, for a geometry which was non-circular. This study highlights the importance of understanding the human anatomy when modelling blood vessels., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
376. Prosthodontic complications during implant-based oral rehabilitation of patients with head and neck cancer.
- Author
-
Laverty DP, Addison O, Newsum D, and Bateman G
- Subjects
- Humans, Retrospective Studies, Prosthodontics, Dental Implantation, Endosseous adverse effects, Postoperative Complications, Dental Prosthesis, Implant-Supported adverse effects, Follow-Up Studies, Treatment Outcome, Dental Implants, Head and Neck Neoplasms surgery
- Abstract
Statement of Problem: Implant-retained prosthodontic rehabilitation of patients with head and neck cancer is complex. However, the extent of prosthodontic complications has been sparsely reported within the literature., Purpose: The purpose of this retrospective study was to describe the range of complications and issues that affected the oral rehabilitation treatment of patients with head and neck cancer who had completed implant-retained prosthodontic rehabilitation in a tertiary treatment center., Material and Methods: A retrospective analysis of complications and their consequences in patients treated in a regional unit from 2012 to 2017 was performed. Descriptive analysis was carried out on the type and frequency of complications and their consequences for the patients' treatment. Complications were grouped into the following complication types: local and systemic, implant, peri-implant soft tissue, and clinical prosthodontic complications. Implant success and implant survival were also reported., Results: The sample was composed of 163 patients with head and neck cancer who had completed implant-retained prosthodontic rehabilitation. Local and systemic complications affected 8.6% of patients, and peri-implant soft-tissue complications affected 9.8% of patients. Clinical prosthodontic complications leading to repeated clinical or laboratory stages occurred on 48 occasions in 45 patients (27.6% of patients). A total of 763 implants were placed. Implant survival was 95.8% and implant success 94.5%, with a mean follow-up of 42.1 months., Conclusions: This retrospective evaluation indicated that complications arising during the process of implant-retained prosthetic rehabilitation in this patient group were variable and common. Such complications can delay the process of treatment and lead to repeating or restarting clinical and laboratory stages of treatment., (Copyright © 2021 Editorial Council for the Journal of Prosthetic Dentistry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
377. Great balls of fire: activation and signalling of inflammatory caspases.
- Author
-
Bateman G, Hill B, Knight R, and Boucher D
- Subjects
- Animals, Caspases metabolism, Cytokines metabolism, Enzyme Activation immunology, Humans, Inflammasomes metabolism, Inflammation metabolism, Pyroptosis immunology, Substrate Specificity, Caspases immunology, Cytokines immunology, Inflammasomes immunology, Inflammation immunology, Signal Transduction immunology
- Abstract
Innate immune responses are tightly regulated by various pathways to control infections and maintain homeostasis. One of these pathways, the inflammasome pathway, activates a family of cysteine proteases called inflammatory caspases. They orchestrate an immune response by cleaving specific cellular substrates. Canonical inflammasomes activate caspase-1, whereas non-canonical inflammasomes activate caspase-4 and -5 in humans and caspase-11 in mice. Caspases are highly specific enzymes that select their substrates through diverse mechanisms. During inflammation, caspase activity is responsible for the secretion of inflammatory cytokines and the execution of a form of lytic and inflammatory cell death called pyroptosis. This review aims to bring together our current knowledge of the biochemical processes behind inflammatory caspase activation, substrate specificity, and substrate signalling., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
378. A transvenous pressure gradient mechanism behind ventriculomegaly.
- Author
-
Bateman G
- Subjects
- Aging, Cerebral Ventricles, Humans, Brain Injuries, Traumatic, Hydrocephalus diagnostic imaging, Nervous System Malformations
- Published
- 2020
- Full Text
- View/download PDF
379. A Class of Fe III Macrocyclic Complexes with Alcohol Donor Groups as Effective T 1 MRI Contrast Agents.
- Author
-
Snyder EM, Asik D, Abozeid SM, Burgio A, Bateman G, Turowski SG, Spernyak JA, and Morrow JR
- Subjects
- Animals, Hydrogen-Ion Concentration, Kidney diagnostic imaging, Liver diagnostic imaging, Mice, Mice, Inbred BALB C, Molecular Conformation, Contrast Media chemistry, Coordination Complexes chemistry, Ferric Compounds chemistry, Magnetic Resonance Imaging methods
- Abstract
Early studies suggested that Fe
III complexes cannot compete with GdIII complexes as T1 MRI contrast agents. Now it is shown that one member of a class of high-spin macrocyclic FeIII complexes produces more intense contrast in mice kidneys and liver at 30 minutes post-injection than does a commercially used GdIII agent and also produces similar T1 relaxivity in serum phantoms at 4.7 T and 37 °C. Comparison of four different FeIII macrocyclic complexes elucidates the factors that contribute to relaxivity in vivo including solution speciation. Variable-temperature17 O NMR studies suggest that none of the complexes has a single, integral inner-sphere water that exchanges rapidly on the NMR timescale. MRI studies in mice show large in vivo differences of three of the FeIII complexes that correspond, in part, to their r1 relaxivity in phantoms. Changes in overall charge of the complex modulate contrast enhancement, especially of the kidneys., (© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2020
- Full Text
- View/download PDF
380. Unusual cause for recurrent epididymo-orchitis: fistula from rectal stump to seminal vesicle.
- Author
-
Storey B, Smith S, Bateman G, and McLeod N
- Subjects
- Adolescent, Humans, Male, Recurrence, Epididymitis etiology, Fistula complications, Genital Diseases, Male complications, Orchitis etiology, Rectal Fistula complications, Seminal Vesicles
- Published
- 2020
- Full Text
- View/download PDF
381. Are gait changes linked to CSF flow changes in the sagittal sinus?
- Author
-
Gallagher R, Bateman G, Marquez J, and Osmotherly P
- Subjects
- Aged, Female, Gait Disorders, Neurologic physiopathology, Humans, Hydrocephalus, Normal Pressure physiopathology, Male, Prospective Studies, Treatment Outcome, Cerebrospinal Fluid Shunts, Gait Disorders, Neurologic cerebrospinal fluid, Gait Disorders, Neurologic therapy, Hydrocephalus, Normal Pressure cerebrospinal fluid, Hydrocephalus, Normal Pressure therapy, Magnetic Resonance Imaging methods, Superior Sagittal Sinus diagnostic imaging
- Abstract
Purpose: To identify if specific findings on magnetic resonance imaging (MRI) cerebrospinal fluid (CSF) flow studies can be utilised to identify which patients with idiopathic normal pressure hydrocephalus (iNPH) will have improved gait following a CSF tap test (TT)., Methods: Prospective study of patients undergoing a CSF TT for iNPH. Functional gait was assessed using the timed up and go (TUG) test before and after the CSF TT. MRI CSF flow studies accompanied the CSF TT. The minimum clinically important difference for the TUG (3.63 s) was used as a cutoff value to categorise patients as responders to the CSF TT., Results: Fifty-three patients underwent CSF TT and MRI CSF flow studies. Significant differences were identified between groups for (non-responder vs responder) superior sagittal sinus flow (47.10% vs 40.41%), sagittal sinus stroke volume (274 vs 176.5 μl), sagittal sinus to arterial stroke volume ratio (0.203 vs 0.164), sagittal sinus area (42.2 mm
2 vs 36.2 mm2 ) and circumference (27.7 mm vs 24.95 mm). No differences were present for aqueduct stroke volume, arterial stroke volume or aqueduct net flow., Conclusion: A link between gait improvement resulting from CSF drainage and sagittal sinus measurements indicates that the sagittal sinus may play a role in the manifestation of symptoms in iNPH. This may have implications for the diagnosis of iNPH and potentially inform clinical decision making regarding surgical intervention.- Published
- 2019
- Full Text
- View/download PDF
382. Outcomes of implant-based oral rehabilitation in head and neck oncology patients-a retrospective evaluation of a large, single regional service cohort.
- Author
-
Laverty DP, Addison O, Wubie BA, Heo G, Parmar S, Martin T, Praveen P, Pearson D, Newsum D, Murphy M, and Bateman G
- Abstract
Background: The study reports on implant survival outcomes in head and neck cancer patients who received implant-based oral rehabilitation in a regional service centre., Methods: A retrospective analysis of implant survival outcomes in patients treated in a regional service from 2012 to 2017 was performed. The primary outcome measure was implant survival. The secondary outcome measure was to assess the effect of covariates associated with implant failure including bone type, radiotherapy, chemotherapy, gender and surgical implant complications. Kaplan-Meier survival curves were applied to compare differences in the survival rates of groups of variables. Cox proportional hazards models were applied to identify covariates associated with implant failure. p value was set at 0.05., Results: The sample was composed of 167 head and neck cancer patients who had 779 dental implants placed. Implant survival estimates were calculated: 3 years, 95.7% [95%CI 94.3-97.2%] and 5 years, 95.5% [95%CI 93.9-97.0%], with a median follow-up of 38 months. Gender (p = 0.09), radiotherapy (p = 0.16) and chemotherapy (p = 0.17) did not significantly influence implant survival, whereas implant failure was higher in transported (reconstructed) bone sites in comparison with native bone (p < 0.01)., Conclusion: The result of this study suggests that overall implant survival as part of the routine oral rehabilitation is high in this patient cohort; however, implant failure was found to be statistically higher for implant placed into transported bone in comparison to native bone.
- Published
- 2019
- Full Text
- View/download PDF
383. Differences in the Calculated Transvenous Pressure Drop between Chronic Hydrocephalus and Idiopathic Intracranial Hypertension.
- Author
-
Bateman GA and Bateman AR
- Subjects
- Adult, Cranial Sinuses diagnostic imaging, Female, Humans, Intracranial Pressure physiology, Male, Middle Aged, Young Adult, Cranial Sinuses physiopathology, Hydrocephalus physiopathology, Pseudotumor Cerebri physiopathology
- Abstract
Background and Purpose: Chronic hydrocephalus is associated with dilated ventricles despite a normal intracranial pressure. In idiopathic intracranial hypertension, the ventricles are normal despite an elevated intracranial pressure. This apparent paradox has largely remained unexplained. It is suggested that a pressure difference between the superficial and deep venous territories of the brain could account for the variation between the 2 diseases. The purpose of this paper is to investigate the cause of this pressure difference., Materials and Methods: Using MR phase-contrast imaging, we calculated the hydraulic diameters of the sagittal and straight sinuses in 21 patients with hydrocephalus, 20 patients with idiopathic intracranial hypertension, and 20 age-matched controls. The outflow resistance of each sinus was estimated using the Poiseuille equation. The outflow pressure was estimated using the flow data. A smaller subset of the patients with hydrocephalus had these studies repeated after successful shunt insertion., Results: In hydrocephalus, the sagittal sinuses were 21% smaller than those in controls ( P < .001); the straight sinuses were not significantly different. In idiopathic intracranial hypertension, both sinuses were not significantly different from those of controls. The pressure drop from the sagittal sinus to the end of the straight sinus was elevated by 1.2 mm Hg in hydrocephalus ( P = .001) but not significantly different from that in controls in idiopathic intracranial hypertension. Shunt insertion dilated the sagittal sinuses in hydrocephalus, leaving them 18% larger than normal and eliminating the transvenous pressure change., Conclusions: There is a transvenous pressure difference in hydrocephalus that is absent in idiopathic intracranial hypertension. This difference is eliminated by shunt insertion. The findings may have a bearing on ventricular dilation., (© 2019 by American Journal of Neuroradiology.)
- Published
- 2019
- Full Text
- View/download PDF
384. Hybrid organic-inorganic crystal structure of 4-(di-methyl-amino)-pyridinium di-methyl-ammonium tetra-chlorido-lead(II).
- Author
-
Benson CA, Bateman G, Cox JM, and Benedict JB
- Abstract
The title compound, (C
2 H8 N)(C7 H11 N2 )[PbCl4 ], is a hybrid organic-inorganic material. It crystallizes in the space group C 2/ c and contains one half of a mol-ecule of lead chloride, 4-(di-methyl-amino)-pyridinium, and di-methyl-ammonium in the asymmetric unit. The crystal structure exhibits chains of lead chloride capped by 4-(di-methyl-amino)-pyridinium and di-methyl-ammoium by hydrogen bonding. This creates a one-dimensional zipper-like structure down the a axis. The crystal structure is examined and compared to a similar structure containing lead chloride and di-methyl-benzene-1,4-diaminium.- Published
- 2017
- Full Text
- View/download PDF
385. Solvent exchange in a metal-organic framework single crystal monitored by dynamic in situ X-ray diffraction.
- Author
-
Cox JM, Walton IM, Bateman G, Benson CA, Mitchell T, Sylvester E, Chen YS, and Benedict JB
- Abstract
Understanding the processes by which porous solid-state materials adsorb and release guest molecules would represent a significant step towards developing rational design principles for functional porous materials. To elucidate the process of liquid exchange in these materials, dynamic in situ X-ray diffraction techniques have been developed which utilize liquid-phase chemical stimuli. Using these time-resolved diffraction techniques, the ethanol solvation process in a flexible metal-organic framework [Co(AIP)(bpy)
0.5 (H2 O)]·2H2 O was examined. The measurements provide important insight into the nature of the chemical transformation in this system including the presence of a previously unreported neat ethanol solvate structure.- Published
- 2017
- Full Text
- View/download PDF
386. A Randomized Controlled Trial of the Effect of Early Upper-Limb Training on Stroke Recovery and Brain Activation.
- Author
-
Hubbard IJ, Carey LM, Budd TW, Levi C, McElduff P, Hudson S, Bateman G, and Parsons MW
- Subjects
- Adult, Aged, Aged, 80 and over, Brain Ischemia complications, Brain Ischemia physiopathology, Brain Mapping, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Movement Disorders etiology, Movement Disorders physiopathology, Neuronal Plasticity physiology, Prospective Studies, Recovery of Function physiology, Single-Blind Method, Stroke complications, Stroke physiopathology, Time Factors, Treatment Outcome, Brain physiopathology, Brain Ischemia rehabilitation, Exercise Therapy methods, Movement Disorders rehabilitation, Stroke Rehabilitation, Upper Extremity physiopathology
- Abstract
Background: Upper-limb (UL) dysfunction is experienced by up to 75% of patients poststroke. The greatest potential for functional improvement is in the first month. Following reperfusion, evidence indicates that neuroplasticity is the mechanism that supports this recovery., Objective: This preliminary study hypothesized increased activation of putative motor areas in those receiving intensive, task-specific UL training in the first month poststroke compared with those receiving standard care., Methods: This was a single-blinded, longitudinal, randomized controlled trial in adult patients with an acute, first-ever ischemic stroke; 23 participants were randomized to standard care (n = 12) or an additional 30 hours of task-specific UL training in the first month poststroke beginning week 1. Patients were assessed at 1 week, 1 month, and 3 months poststroke. The primary outcome was change in brain activation as measured by functional magnetic resonance imaging., Results: When compared with the standard-care group, the intensive-training group had increased brain activation in the anterior cingulate and ipsilesional supplementary motor areas and a greater reduction in the extent of activation (P = .02) in the contralesional cerebellum. Intensive training was associated with a smaller deviation from mean recovery at 1 month (Pr>F0 = 0.017) and 3 months (Pr>F = 0.006), indicating more consistent and predictable improvement in motor outcomes., Conclusion: Early, more-intensive, UL training was associated with greater changes in activation in putative motor (supplementary motor area and cerebellum) and attention (anterior cingulate) regions, providing support for the role of these regions and functions in early recovery poststroke., (© The Author(s) 2014.)
- Published
- 2015
- Full Text
- View/download PDF
387. Perfusion computed tomography to assist decision making for stroke thrombolysis.
- Author
-
Bivard A, Levi C, Krishnamurthy V, McElduff P, Miteff F, Spratt NJ, Bateman G, Donnan G, Davis S, and Parsons M
- Subjects
- Administration, Intravenous, Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Middle Aged, Prospective Studies, Tomography, X-Ray Computed methods, Fibrinolytic Agents administration & dosage, Stroke drug therapy, Thrombolytic Therapy methods, Tissue Plasminogen Activator administration & dosage
- Abstract
The use of perfusion imaging to guide selection of patients for stroke thrombolysis remains controversial because of lack of supportive phase three clinical trial evidence. We aimed to measure the outcomes for patients treated with intravenous recombinant tissue plasminogen activator (rtPA) at a comprehensive stroke care facility where perfusion computed tomography was routinely used for thrombolysis eligibility decision assistance. Our overall hypothesis was that patients with 'target' mismatch on perfusion computed tomography would have improved outcomes with rtPA. This was a prospective cohort study of consecutive ischaemic stroke patients who fulfilled standard clinical/non-contrast computed tomography eligibility criteria for treatment with intravenous rtPA, but for whom perfusion computed tomography was used to guide the final treatment decision. The 'real-time' perfusion computed tomography assessments were qualitative; a large perfusion computed tomography ischaemic core, or lack of significant perfusion lesion-core mismatch were considered relative exclusion criteria for thrombolysis. Specific volumetric perfusion computed tomography criteria were not used for the treatment decision. The primary analysis compared 3-month modified Rankin Scale in treated versus untreated patients after 'off-line' (post-treatment) quantitative volumetric perfusion computed tomography eligibility assessment based on presence or absence of 'target' perfusion lesion-core mismatch (mismatch ratio >1.8 and volume >15 ml, core <70 ml). In a second analysis, we compared outcomes of the perfusion computed tomography-selected rtPA-treated patients to an Australian historical cohort of non-contrast computed tomography-selected rtPA-treated patients. Of 635 patients with acute ischaemic stroke eligible for rtPA by standard criteria, thrombolysis was given to 366 patients, with 269 excluded based on visual real-time perfusion computed tomography assessment. After off-line quantitative perfusion computed tomography classification: 253 treated patients and 83 untreated patients had 'target' mismatch, 56 treated and 31 untreated patients had a large ischaemic core, and 57 treated and 155 untreated patients had no target mismatch. In the primary analysis, only in the target mismatch subgroup did rtPA-treated patients have significantly better outcomes (odds ratio for 3-month, modified Rankin Scale 0-2 = 13.8, P < 0.001). With respect to the perfusion computed tomography selected rtPA-treated patients (n = 366) versus the clinical/non-contrast computed tomography selected rtPA-treated patients (n = 396), the perfusion computed tomography selected group had higher adjusted odds of excellent outcome (modified Rankin Scale 0-1 odds ratio 1.59, P = 0.009) and lower mortality (odds ratio 0.56, P = 0.021). Although based on observational data sets, our analyses provide support for the hypothesis that perfusion computed tomography improves the identification of patients likely to respond to thrombolysis, and also those in whom natural history may be difficult to modify with treatment., (© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain.)
- Published
- 2015
- Full Text
- View/download PDF
388. Effect of selected manual therapy interventions for mechanical neck pain on vertebral and internal carotid arterial blood flow and cerebral inflow.
- Author
-
Thomas LC, Rivett DA, Bateman G, Stanwell P, and Levi CR
- Subjects
- Adult, Carotid Arteries physiopathology, Female, Humans, Magnetic Resonance Angiography, Male, Middle Aged, Posture, Regional Blood Flow, Rotation, Vertebral Artery physiopathology, Young Adult, Cerebrum blood supply, Musculoskeletal Manipulations adverse effects, Neck Pain therapy
- Abstract
Background: Manual therapy of the cervical spine has occasionally been associated with serious adverse events involving compromise of the craniocervical arteries. Ultrasound studies have shown certain neck positions can alter craniocervical arterial blood flow velocities; however, findings are conflicting. Knowledge about the effects of neck position on blood flow may assist clinicians in avoiding potentially hazardous practices., Objective: The purpose of this study was to examine the effects of selected manual therapeutic interventions on blood flow in the craniocervical arteries and blood supply to the brain using magnetic resonance angiography (MRA)., Design: This was an experimental, observational magnetic resonance imaging study., Method: Twenty adult participants who were healthy and had a mean age of 33 years were imaged using MRA in the following neck positions: neutral, rotation, rotation/distraction (similar to a Cyriax manipulation), C1-C2 rotation (similar to a Maitland or osteopathic manipulation), and distraction., Results: The participants were imaged using 3T MRA. All participants had normal vascular anatomy. Average inflow to the brain in neutral was 6.98 mL/s and was not significantly changed by any of the test positions. There was no significant difference in flow in any of the 4 arteries in any position from neutral, despite large individual variations., Limitations: Only individuals who were asymptomatic were investigated, and a short section of the arteries only were imaged., Conclusions: Blood flow to the brain does not appear to be compromised by positions commonly used in manual therapy. Positions using end-range neck rotation and distraction do not appear to be more hazardous to cerebral circulation than more segmentally localized techniques.
- Published
- 2013
- Full Text
- View/download PDF
389. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
- Author
-
Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O'Brien B, Bladin C, McElduff P, Allen C, Bateman G, Donnan G, Davis S, and Levi C
- Subjects
- Aged, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents administration & dosage, Fibrinolytic Agents adverse effects, Humans, Male, Middle Aged, Single-Blind Method, Tenecteplase, Tissue Plasminogen Activator administration & dosage, Tissue Plasminogen Activator adverse effects, Treatment Outcome, Brain Ischemia drug therapy, Fibrinolytic Agents therapeutic use, Stroke drug therapy, Tissue Plasminogen Activator therapeutic use
- Abstract
Background: Intravenous alteplase is the only approved treatment for acute ischemic stroke. Tenecteplase, a genetically engineered mutant tissue plasminogen activator, is an alternative thrombolytic agent., Methods: In this phase 2B trial, we randomly assigned 75 patients to receive alteplase (0.9 mg per kilogram of body weight) or tenecteplase (0.1 mg per kilogram or 0.25 mg per kilogram) less than 6 hours after the onset of ischemic stroke. To favor the selection of patients most likely to benefit from thrombolytic therapy, the eligibility criteria were a perfusion lesion at least 20% greater than the infarct core on computed tomographic (CT) perfusion imaging at baseline and an associated vessel occlusion on CT angiography. The coprimary end points were the proportion of the perfusion lesion that was reperfused at 24 hours on perfusion-weighted magnetic resonance imaging and the extent of clinical improvement at 24 hours as assessed on the National Institutes of Health Stroke Scale (NIHSS, a 42-point scale on which higher scores indicate more severe neurologic deficits)., Results: The three treatment groups each comprised 25 patients. The mean (±SD) NIHSS score at baseline for all patients was 14.4±2.6, and the time to treatment was 2.9±0.8 hours. Together, the two tenecteplase groups had greater reperfusion (P=0.004) and clinical improvement (P<0.001) at 24 hours than the alteplase group. There were no significant between-group differences in intracranial bleeding or other serious adverse events. The higher dose of tenecteplase (0.25 mg per kilogram) was superior to the lower dose and to alteplase for all efficacy outcomes, including absence of serious disability at 90 days (in 72% of patients, vs. 40% with alteplase; P=0.02)., Conclusions: Tenecteplase was associated with significantly better reperfusion and clinical outcomes than alteplase in patients with stroke who were selected on the basis of CT perfusion imaging. (Funded by the Australian National Health and Medical Research Council; Australia New Zealand Clinical Trials Registry number, ACTRN12608000466347.).
- Published
- 2012
- Full Text
- View/download PDF
390. Dental dilemmas: endodontics or dental implants?
- Author
-
Bateman G, Barclay CW, and Saunders WP
- Abstract
This narrative review explores treatment planning options in restorative dentistry. The growth of dental implants, as an accessible and predictable treatment option, gives practitioners a useful tool for managing the missing tooth or teeth with a hopeless prognosis. Traditionally, endodontics and fixed prosthodontics have been used to restore teeth and spaces where the outlook for such treatment appears reasonable. Practitioners may, however, question the predictability and cost effectiveness of such an approach where, at times, it might appear that replacement of a compromised tooth with a dental implant could be a more predictable option. The evidence base for these treatment options is explored and discussed, and suggestions are made for future management strategies.
- Published
- 2011
391. Dental dilemmas: Endodontics or dental implants?
- Author
-
Bateman G, Barclay CW, and Saunders WP
- Subjects
- Adolescent, Adult, Costs and Cost Analysis, Dental Prosthesis, Implant-Supported economics, Dental Prosthesis, Implant-Supported psychology, Dental Restoration Failure, Evidence-Based Dentistry, Humans, Male, Post and Core Technique, Quality of Life, Retreatment, Tooth, Nonvital therapy, Treatment Failure, Dental Implantation, Endosseous economics, Dental Implantation, Endosseous psychology, Dental Implantation, Endosseous statistics & numerical data, Dental Implants, Single-Tooth economics, Dental Implants, Single-Tooth psychology, Dental Implants, Single-Tooth statistics & numerical data, Root Canal Therapy economics, Root Canal Therapy psychology, Root Canal Therapy statistics & numerical data
- Abstract
Unlabelled: This narrative review explores treatment planning options in restorative dentistry. The growth of dental implants, as an accessible and predictable treatment option, gives practitioners a useful tool for managing the missing tooth or teeth with a hopeless prognosis. Traditionally, endodontics and fixed prosthodontics have been used to restore teeth and spaces where the outlook for such treatment appears reasonable. Practitioners may, however, question the predictability and cost effectiveness of such an approach where, at times, it might appear that replacement of a compromised tooth with a dental implant could be a more predictable option. The evidence base for these treatment options is explored and discussed, and suggestions are made for future management strategies., Clinical Relevance: A clear knowledge and understanding of the scientific literature for implants and endodontic treatment is necessary if practitioners are to make an evidence-based approach when treatment planning these modalities for their patients. This is particularly true in cases where there may appear to be a reasonable choice between the two of these.
- Published
- 2010
- Full Text
- View/download PDF
392. Hyperemic hydrocephalus: a new form of childhood hydrocephalus analogous to hyperemic intracranial hypertension in adults.
- Author
-
Bateman G
- Subjects
- Adolescent, Adult, Blood Flow Velocity physiology, Blood Volume physiology, Brain blood supply, Cephalometry, Cerebral Aqueduct physiopathology, Child, Child, Preschool, Collateral Circulation physiology, Cranial Sinuses physiopathology, Female, Humans, Hydrocephalus physiopathology, Hyperemia physiopathology, Infant, Intracranial Hypertension physiopathology, Male, Vascular Resistance physiology, Venous Pressure physiology, Hydrocephalus diagnosis, Hyperemia diagnosis, Image Processing, Computer-Assisted, Intracranial Hypertension diagnosis, Magnetic Resonance Imaging
- Abstract
Object: In the majority of adults with idiopathic intracranial hypertension (IIH), there is an elevation in venous pressure associated with a venous outflow stenosis. In about 15% of IIH patients the elevated venous pressure is associated with an elevation in blood flow but little or no evidence of a stenosis. Venostenotic IIH and idiopathic hydrocephalus in children with a normal blood inflow have been shown to be equivalent. The aim of this study was to test whether children with hydrocephalus and an elevated arterial inflow have a vascular pathophysiology that is analogous to the hyperemic form of IIH in adults., Methods: Nine children with idiopathic hydrocephalus underwent MR imaging with flow quantification and were found to have arterial inflows 2 SDs above the mean for normal controls. Measurements of the head circumference, ventricular enlargement, total blood inflow, superior sagittal sinus (SSS)/straight sinus (SS) outflow, and the degree of collateral venous flow were performed. The results were compared with findings in 14 age-matched controls., Results: In hyperemic hydrocephalus the cerebral blood inflow was elevated but the SSS and SS outflows were in the normal range. The sinus outflow as a percentage of the inflow was reduced by 8 percentage points in the SSS territory and 5 percentage points in the SS territory compared with findings in the controls (p = 0.04, p = 0.003, respectively), suggesting blood was returning via collateral channels., Conclusions: Similar to patients with hyperemic IIH, children with hyperemic hydrocephalus show a significant elevation in collateral venous flow, indicating that the same venous pathophysiology may be operating in both conditions.
- Published
- 2010
- Full Text
- View/download PDF
393. A guide to the appraisal of research: 2. What's in a number?
- Author
-
Bateman G, Burke FJ, and Saha S
- Subjects
- Clinical Trials as Topic statistics & numerical data, Confidence Intervals, Follow-Up Studies, Forecasting, Humans, Patient Dropouts statistics & numerical data, Probability, Research Design statistics & numerical data, Sample Size, Time Factors, Dental Research statistics & numerical data, Evidence-Based Dentistry statistics & numerical data
- Abstract
Unlabelled: This review explores the nature of numbers in dental research, their importance and, at a basic level, how these are handled. This includes the important numbers that practitioners should look at when appraising research and discussion of some commonly found statistical terms., Clinical Relevance: In order to apply evidence-based dentistry in clinical practice, dentists should have an understanding of the basic numbers reported in dental research, and an appreciation of this should allow them to identify which papers are most valuable to inform their clinical practice.
- Published
- 2009
- Full Text
- View/download PDF
394. A guide to the appraisal of research: 1. The nature of research.
- Author
-
Bateman G, Burke FJ, and Saha S
- Subjects
- Animal Experimentation, Bias, Controlled Clinical Trials as Topic, Cross-Sectional Studies, Dental Research classification, Guidelines as Topic, Humans, Medical Records, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Research Design standards, Review Literature as Topic, Dental Research standards, Evidence-Based Dentistry standards
- Abstract
Unlabelled: Evidence-based dentistry has grown in recent years. The oceans of journals and research papers can be difficult to navigate. Gauging the quality of such publications and, more importantly, their clinical relevance may be challenging.This narrative review explores the nature and relevance of dental research to clinical dentistry and provides simple guidelines for critical appraisal of such research. In this respect, all dental clinical practice should be underpinned, where possible, with evidence that treatments carried out are contemporary and effective., Clinical Relevance: A working knowledge of dental research and its relevance to clinical practice should allow practitioners to select best evidence to inform their clinical practice.
- Published
- 2009
- Full Text
- View/download PDF
395. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
- Author
-
Parsons MW, Miteff F, Bateman GA, Spratt N, Loiselle A, Attia J, and Levi CR
- Subjects
- Aged, Cerebral Angiography, Cerebrovascular Circulation, Dose-Response Relationship, Drug, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Plasminogen Activators administration & dosage, Prospective Studies, Regression Analysis, Tenecteplase, Tissue Plasminogen Activator administration & dosage, Tomography, X-Ray Computed, Treatment Outcome, Brain Ischemia complications, Plasminogen Activators therapeutic use, Stroke drug therapy, Stroke etiology, Tissue Plasminogen Activator therapeutic use
- Abstract
Background: Tenecteplase is a modified tissue plasminogen activator with a longer half-life and higher fibrin specificity than alteplase., Methods: We conducted a prospective, nonrandomized, pilot study of 0.1 mg/kg IV tenecteplase given 3 to 6 hours after ischemic stroke onset. For a control group, we used patients contemporaneously treated with sub-3-hour 0.9 mg/kg IV alteplase following standard selection criteria. All patients underwent pretreatment and 24-hour perfusion/angiographic imaging with CT or MRI. Eligibility criteria for tenecteplase (but not alteplase) treatment included a perfusion lesion at least 20% greater than the infarct core, with an associated vessel occlusion. Primary outcomes, assessed blind to treatment group, were reperfusion (reduction in baseline-24-hour mean transit time lesion) and major vessel recanalization., Results: Fifteen patients received tenecteplase, and 35 patients received alteplase. The tenecteplase group had greater reperfusion (mean 74% vs 44% in the alteplase group, p = 0.01) and major vessel recanalization (10/15 tenecteplase vs 7/29 alteplase, p = 0.01). Despite later time to treatment, more tenecteplase patients (10/15 vs 7/35 alteplase, p = 0.001) had major neurologic improvement at 24 hours (NIH Stroke Scale reduction > or = 8). Four of the alteplase patients and none of the tenecteplase patients had parenchymal hematoma at 24 hours., Conclusions: Tenecteplase 0.1 mg/kg, using advanced imaging guidance in an extended time window, may have significant biologic efficacy in acute ischemic stroke. The imaging selection differences between the tenecteplase and alteplase groups prevent a conclusive efficacy comparison. Nonetheless, these results lend support for randomized trials comparing tenecteplase with alteplase, preferably incorporating penumbral/angiographic imaging selection.
- Published
- 2009
- Full Text
- View/download PDF
396. The pathophysiology of idiopathic normal pressure hydrocephalus: cerebral ischemia or altered venous hemodynamics?
- Author
-
Bateman GA
- Subjects
- Aged, Blood Flow Velocity, Blood Pressure, Brain pathology, Brain physiopathology, Cerebrovascular Circulation, Female, Humans, Magnetic Resonance Imaging, Male, Retrospective Studies, Brain Ischemia pathology, Brain Ischemia physiopathology, Cerebral Veins pathology, Cerebral Veins physiopathology, Hydrocephalus, Normal Pressure diagnosis, Hydrocephalus, Normal Pressure pathology, Hydrocephalus, Normal Pressure physiopathology
- Abstract
Background and Purpose: Many theories of normal pressure hydrocephalus (NPH) stress the importance of ischemia in the deep white matter. Alternate theories stress a reduction in superficial venous compliance and changes in pulse-wave propagation. An overlap in the cerebral blood flow volumes measured between NPH and controls suggests that ischemia may not be a prerequisite for this condition. This study sought to compare blood flow and compliance measures in a cohort of patients with NPH selected for having arterial inflows above the normal range to see if deep brain ischemia or superficial hemodynamic changes contribute to the pathophysiology of NPH., Materials and Methods: Twenty patients with NPH and arterial inflows above the normal range were selected. They underwent MR imaging with flow quantification measuring the total blood inflow, sagittal/straight sinus outflow, aqueduct stroke volume, and arteriovenous delay (AVD). Patients were compared with 12 age-matched controls., Results: The deep outflow volumes were normal. The superficial venous outflow was reduced as a percentage of the inflow by 9% (P = .04). The sagittal sinus compliance as measured by the AVD was reduced by 50% (P = .0001), and the aqueduct stroke volume was elevated by 192% (P = .02)., Conclusion: Ischemia in the deep venous territory is not a prerequisite for NPH. Patients with high-inflow NPH show alterations in superficial venous compliance and a reduction in the blood flow returning via the sagittal sinus. These changes together suggest that an elevation in superficial venous pressure may occur in NPH.
- Published
- 2008
- Full Text
- View/download PDF
397. Identification of the penumbra and infarct core on hyperacute noncontrast and perfusion CT.
- Author
-
Parsons MW, Pepper EM, Bateman GA, Wang Y, and Levi CR
- Subjects
- Aged, Brain Edema diagnostic imaging, Brain Ischemia complications, Brain Ischemia diagnostic imaging, Brain Mapping, Disease Progression, Female, Humans, Logistic Models, Male, Middle Aged, Perfusion, Stroke etiology, Blood Volume, Cerebral Infarction diagnostic imaging, Cerebrovascular Circulation, Stroke diagnostic imaging, Tomography, X-Ray Computed methods
- Abstract
Objectives: To correlate the two types of early ischemic change on noncontrast CT (NCCT) (parenchymal hypoattenuation [PH] and isolated focal swelling [IFS]) with concurrent assessment of cerebral perfusion and to compare their rates of progression to infarction., Methods: We assessed cortical regions on NCCT for early ischemic change. Quantitative perfusion values were calculated for cortical regions from acute CT perfusion (CTP) maps of cerebral blood volume (CBV), blood flow (CBF), and mean transit time (MTT). Reperfusion and presence of infarction were determined from follow-up MRI., Results: We studied 40 patients with sub-6 hour anterior circulation ischemic stroke; 19 received IV recombinant tissue plasminogen activator. Of the 202 regions acutely hypoperfused on CTP, 123 were normal on NCCT, 58 had PH, and 21 had IFS. Acute CBV was low in PH regions, and elevated in IFS regions. Acute CBF was reduced in IFS regions, but more so in PH regions. Progression to infarction occurred in virtually all PH regions, but IFS regions had much lower rates of infarction with major reperfusion. Acute CBV in hypoperfused normal NCCT regions ranged from reduced to elevated, with substantially differing risk of infarction., Conclusions: Isolated focal swelling identifies penumbral tissue and parenchymal hypoattenuation identifies infarct core. Although this has prognostic implications when assessing patient suitability for thrombolytic therapy, the majority of acutely hypoperfused regions appear normal on noncontrast CT. Perfusion CT can stratify the level of risk of subsequent infarction for normal-appearing regions on noncontrast CT.
- Published
- 2007
- Full Text
- View/download PDF
398. Can MR measurement of intracranial hydrodynamics and compliance differentiate which patient with idiopathic normal pressure hydrocephalus will improve following shunt insertion?
- Author
-
Bateman GA and Loiselle AM
- Subjects
- Aged, Aged, 80 and over, Blood Flow Velocity physiology, Cerebral Ventricles pathology, Cerebral Ventricles physiopathology, Compliance, Female, Follow-Up Studies, Humans, Hydrocephalus, Normal Pressure pathology, Male, Predictive Value of Tests, Retrospective Studies, Treatment Outcome, Cerebrospinal Fluid Shunts, Cerebrovascular Circulation physiology, Hydrocephalus, Normal Pressure physiopathology, Hydrocephalus, Normal Pressure surgery, Magnetic Resonance Imaging
- Abstract
Background: Between 10 and 90% of patients with normal pressure hydrocephalus (NPH) treated with a shunt will improve but they risk significant morbidity/mortality from this procedure. NPH is treated hydrodynamically and it has been assumed that a hydrodynamic difference must exist to differentiate which patient will respond. The purpose of this study is to see whether MRI hydrodynamics can differentiate which patients will improve post shunting., Method: Thirty-two patients with NPH underwent MRI with flow quantification measuring the degree of ventricular enlargement, sulcal compression, white matter disease, total blood inflow, sagittal sinus outflow, aqueduct stroke volume, relative compliance ratio and arteriovenous delay. Patients were followed up after shunt insertion to gauge the degree of improvement and were compared with 12 age-matched controls and 12 patients with Alzheimer's disease., Findings: 63% of patients improved with insertion. The responders were identical to the non-responders in all variables. The NPH patients were significantly different to the controls (e.g. Total blood inflow reduced 20%, sagittal sinus outflow reduced 35%, aqueduct stroke volume increased 210%, relative compliance ratio reduced 60% and arteriovenous delay reduced 57% with p = 0.007, 0.03, 0.04, 0.0002 and 0.0003 respectively. The patient's with Alzheimer's disease values were midway between the NPH and control patients., Conclusions: Significant hydrodynamic differences were noted between NPH and controls but these were unable to differentiate the responders from non-responders. The hydrodynamics of Alzheimer's disease makes exclusion of comorbidity from this disease difficult.
- Published
- 2007
- Full Text
- View/download PDF
399. Ectopia or concomitant hypohyperdontia? A case report.
- Author
-
Bateman G and Mossey PA
- Subjects
- Bicuspid diagnostic imaging, Child, Diagnosis, Differential, Female, Humans, Orthodontics, Corrective, Radiography, Panoramic, Space Maintenance, Orthodontic, Tooth Extraction, Anodontia diagnostic imaging, Bicuspid abnormalities, Malocclusion therapy, Tooth Eruption, Ectopic diagnostic imaging, Tooth, Supernumerary diagnostic imaging
- Abstract
This report describes the unusual appearance seen on a panoramic radiograph of an orthodontic patient which the authors argue may represent ectopia or concomitant hypohyperdontia of the mandibular premolar teeth. A literature review describes the frequency of such anomalies in this area from previous studies. The presenting features of the patient and the differential diagnoses are explored. Treatment planning is discussed and treatment carried out in this particular case is detailed. The unusual symmetrical bilateral anomalies in this patient may point to a genetic determinant of tooth germ position and/or movement.
- Published
- 2006
- Full Text
- View/download PDF
400. An investigation into the bonding of orthodontic attachments to porcelain.
- Author
-
Larmour CJ, Bateman G, and Stirrups DR
- Subjects
- Acrylic Resins, Aluminum Silicates, Analysis of Variance, Bisphenol A-Glycidyl Methacrylate, Dental Debonding, Resin Cements, Silanes, Survival Analysis, Tooth, Artificial, Acid Etching, Dental methods, Dental Bonding, Dental Porcelain, Glass Ionomer Cements, Orthodontic Brackets
- Abstract
This study assessed bonding of orthodontic brackets to porcelain teeth using two different surface preparation techniques and comparing two bonding systems, Fuji Ortho L.C. and Transbond. Four groups of 20 porcelain premolar teeth were bonded with metal orthodontic brackets (0.022 inch Minitwin, 3M Unitek) according to the following protocol: Transbond with a phosphoric acid etch (group 1), Transbond with a hydrofluoric acid etch (group 2), Fuji Ortho L.C. with a hydrofluoric acid etch (group 3), and Fuji Ortho L.C. with a phosphoric acid etch (group 4). All groups were bonded with a silane coupling agent. The teeth were debonded with an Instron universal testing machine. Bond strength, site of bond failure and adhesive remnant index (ARI) were recorded for each group. Differences between groups were analysed statistically. The composite resin groups (groups 1 and 2) had the highest mean bond strength values at 7.9 and 9.7 MPa, respectively. The resin-modified glass ionomer cement groups (RMGIC; groups 3 and 4) had the lowest mean bond strength values at 6.3 and 1.8 MPa, respectively. The mean bond strength of group 3 was significantly lower than all other groups (P < 0.0001). The Fuji groups had also significantly (P < 0.001) lower ARI scores than the composite groups (groups 1 and 2). Most samples experienced porcelain surface damage, except group 4. In conclusion, the highest bond strength levels were achieved with a conventional composite resin cement (groups 1 and 2). No significant differences in bond strength were found between the hydrofluoric and phosphoric acid etch technique.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.